Thiophene based apyrase inhibitors

Abstract

Disclosed herein are apyrase inhibitors of Formula (I): (I). Also disclosed herein are methods for using the disclosed inhibitors, including in methods for protecting crops from pests. In one aspect the apyrase inhibitors are useful for enhancing the activity of pesticides for the protection of crops from pathogens and to support crop yield.

Description

[0001] THIOPHENE BASED APYRASE INHIBITORS

[0002] CROSS REFERENCE TO RELATED APPLICATION

[0003] This application claims the benefit of the earlier filing date of U.S. provisional patent application No. 63 / 712,156, filed October 25, 2024, which is incorporated herein by reference in its entirety.

[0004] FIELD

[0005] The present disclosure relates to inhibitors of apyrase and methods for their use, in particular in the treatment of crops susceptible to pathogens.

[0006] BACKGROUND

[0007] Crops are plagued worldwide by a variety of pests. These pests, such as insects, mites, nematodes, weeds and fungi, have developed an array of mechanisms for surviving pesticides, such as by sequestering, exporting or detoxifying them. The present inventors have discovered molecules and methods for potentiating the efficacy of pesticides by blocking certain mechanisms of resistance.

[0008] SUMMARY

[0009] Disclosed herein are molecules and methods for their use in supporting crop viability and yield, by, for example, protecting crops from pests. In one embodiment, disclosed herein is a method for inhibiting apyrase enzymes, comprising contacting the apyrase with a compound of the formula , wherein

[0010] Z1, Z2, R1, R2and X are as described herein.

[0011] In further embodiments, an apyrase inhibitor as described herein is used in combination with one or more pesticides to treat a crop at risk of disease.

[0012] The foregoing and other objects, features, and advantages of the invention will become more apparent from the following detailed description.

[0013] DETAILED DESCRIPTION

[0014] I. Terms

[0015] The following explanations of terms and methods are provided to better describe the present disclosure and to guide those of ordinary skill in the art in the practice of the present disclosure. The singular forms “a,” “an,” and “the” refer to one or more than one, unless the context clearly dictates otherwise. The term “or” refers to a single element of stated alternative elements or a combination of two or more elements, unless the context clearly indicates otherwise. As used herein, “comprises” means “includes.” Thus, “comprising A or B,” means “including A, B, or A and B,” without excluding additional elements. All references, including patents and patent applications cited herein, are incorporated by reference in their entirety, unless otherwise specified.

[0016] Unless otherwise indicated, all numbers expressing quantities of components, molecular weights, percentages, temperatures, times, and so forth, as used in the specification or claims, are to be understood as being modified by the term “about.” Accordingly, unless otherwise indicated, implicitly or explicitly, the numerical parameters set forth are approximations that may depend on the desired properties sought and / or limits of detection under standard test conditions / methods. When directly and explicitly distinguishing embodiments from discussed prior art, the embodiment numbers are not approximates unless the word “about” is expressly recited.

[0017] Unless explained otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure pertains. Although methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present disclosure, suitable methods and materials are described below. The materials, methods, and examples are illustrative only and not intended to be limiting.

[0018] “Administering” refers to any suitable mode of administration, to control a fungal pathogen, including, treatment of an extant crop, seeds, soil or combination thereof.

[0019] “Control” with reference to a fungal pathogen, means block, inhibit and / or eradicate a fungal pathogen and / or prevent the fungal pathogen from damaging a crop. In one embodiment, control refers to the reduction of one or more fungi to undetectable levels, or to the reduction or suppression of a fungus to acceptable levels as determined by one of ordinary skill in the art (for example, a crop grower). Determinations of acceptable levels of fungus reduction are based on a number of factors, including to the crop, pathogen, severity of the pathogen, use restrictions, economic thresholds and other factors known to those of ordinary skill in the art.

[0020] As used herein, the terms “enhancer” and "potentiator", refer to a compound or compounds disclosed herein that enhance the effects of a pesticide. Without limitation to theory the present enhancer compounds disclosed herein may function by blocking one or more pathways by which a pathogen, such as a fungal pathogen, evades toxicity, such as by detoxifying, sequestering or transporting a pesticide. In certain embodiment, the present compounds inhibit enzymatic apyrase activity which leads to the enhancement, accentuation or potentiation of a pesticide, such as an acaricide, antimicrobial, fungicide, herbicide, insecticide, molluscicide and / or nematocide. For example, when the enhancer or potentiator is used in conjunction with a fungicide, the combination of the potentiator and the fungicide enhances the fungicidal effect of the fungicide and / or renders a fungus that has become resistant to the fungicide susceptible to the fungicide as a result of the activity of the potentiator. Most often, these enhancers or potentiators do not themselves inhibit the growth of a fungus itself, nor do they have a detrimental effect on a living organism that is (or could be) infected with a fungus.

[0021] As used herein, the term "inoculation" refers to a method used to administer or apply an effective amount of a disclosed compound or formulation thereof to a target area of a field and / or plant. The inoculation method can be, but is not limited to, aerosol spray, pressure spray, direct watering, and dipping. Target areas of a plant could include, but are not limited to, the leaves, roots, stems, buds, flowers, fruit, seed of the plant, and bulbs of the plant including bulb, corm, rhizoma, stem tuber, root tuber and rhizophore. Inoculation can include a method wherein a plant is treated in one area (for example, the root zone or foliage) and another area of the plant becomes protected (for example, foliage is inoculated when a disclosed compound is applied in the root zone or new growth when applied to foliage).

[0022] As used herein, the terms "wettable granule", "water dispersible granule", and "dispersible granule" refer to a solid granular formulation prepared by a granulation process, optionally containing fine particles of polymer-associated active ingredient, or aggregates of the same, a wetting agent and / or a dispersant, and optionally an inert filler. Wettable granules can be stored as a formulation, and can be provided to the market and / or end user without further processing. In some embodiments, they can be placed in a water-soluble bag for ease of use by the end user. In practical application, wettable granules are prepared for application by the end user. The wettable granules are mixed with water in the end user's spray tank to the proper dilution for the particular application. Dilution can vary by crop, target pathogen, time of year, geography, local regulations, and intensity of infection or pathogen load among other factors. Once properly diluted, the solution can be applied by spraying.

[0023] As used herein, the terms "wettable powder", "water dispersible powder", and "dispersible powder", refer to a solid powdered formulation that contains active ingredient, optionally associated with a polymer, or aggregates of the same, and optionally one or more of a dispersant, a wetting agent, and an inert filler. Wettable powders can be stored as a formulation, and can be provided to the market and / or end user without further processing. In some embodiments, they can be placed in a water-soluble bag for ease of use by the end user. In practical application, a wettable powder is prepared for application by the end user. The wettable powder is mixed with water in the end user's spray tank to the proper dilution for the particular application. Dilution can vary by crop, fungal pathogen, time of year, geography, local regulations, and intensity of fungal load, among other factors. Once properly diluted, the solution can be applied by spraying. As used herein, the term "high solids liquid suspension" refers to a liquid formulation that contains fine particles of active ingredient, or fine polymer particles associated with active ingredient, or aggregates of the same, a wetting agent and / or a dispersant, an anti-freezing agent, optionally an antisettling agent or thickener, optionally a preservative, and water or oil as a carrier. High solids liquid suspensions can be stored as a formulation, and can be provided to the market and / or end user without further processing. In practical application, high solids liquid suspensions are prepared for application by the end user. The high solids liquid suspensions are mixed with water or oil in the end user's spray tank to the proper dilution for the particular application. Dilution can vary by crop, fungal pathogen, time of year, geography, local regulations, and intensity of infection among other factors. Once properly diluted, the solution can be applied by spraying.

[0024] As used herein, the term "phytologically acceptable" refers to compositions, diluents, excipients, and / or carriers that are generally applicable for use with any part of a plant during any part of its life cycle, including but not limited to seeds, seedlings, plant cells, plants, or flowers. The compositions can be prepared according to procedures, methods and formulas that are known to those of skill in the agricultural arts. Following the teachings of the present disclosure the artist skilled in the agricultural and / or chemical arts can readily prepare a desired composition. Most commonly, the compounds disclosed herein can be formulated to be stored, and / or applied, as aqueous or non-aqueous suspensions or emulsions prepared neat or from concentrated formulations of the compositions. Alternatively the compounds disclosed herein can be formulated for use in aerosol-generating equipment for application to agricultural produce stored in sealed chambers - an application method known as fogging. Watersoluble, water-suspendable or emulsifiable formulations comprising the presently disclosed compounds can also be converted into or formulated as solids (for example, wettable powders), which can then be diluted into a final formulation. In certain formulations, the compositions of the present disclosure can also be provided in growth media, such as in vitro media for growth of plant or other types of cells, in laboratory plant growth media, in soil, or for spraying on seeds, seedlings, roots, stems, stalks, leaves, flowers or the entire plant.

[0025] Compounds herein can include all stereoisomers, including E and Z isomers, enantiomers, diastereomers, mixtures, racemates, atropisomers, and tautomers of the illustrated structures.

[0026] Non-limiting examples of optional substituents include hydroxyl groups, sulfhydryl groups, halogens, amino groups, nitro groups, nitroso groups, cyano groups, azido groups, sulfoxide groups, sulfone groups, sulfonamide groups, carboxyl groups, carboxaldehyde groups, imine groups, alkyl groups, halo-alkyl groups, alkenyl groups, haloalkenyl groups, alkynyl groups, halo-alkynyl groups, alkoxy groups, aryl groups, aryloxy groups, aralkyl groups, arylalkoxy groups, heterocyclylalkyl groups, heteroaryl groups, cycloalkyl groups, acyl groups, acyloxy groups, carbamate groups, amide groups, ureido groups, epoxy groups, and ester groups.

[0027] “Alkyl” refers to an optionally substituted straight-chain, or optionally substituted branched-chain saturated hydrocarbon. Non-limiting examples of alkyl groups include straight, branched, and cyclic alkyl and alkylene groups. An alkyl group can be, for example, a Ci, C2, C3, C4, C5, C&, C7, Cs, C9, C10, C11, C12, C13, Ci4. C15, Ci6, C17, Cis, Ci9, C20, C21, C22. C23, C24, C25, C26, C27, C28, C29, C30. C31, C32, C33. C34, C35, C.36, C37, C.3S, C39, C40, C41, C42, C43, C44, C45, C.46, C47, C48, C49, or C50 group that is substituted or unsubstituted. In some cases alkyl refers to a group having from one to about ten carbon atoms, or from one to six carbon atoms, wherein an sp3-hybridized carbon of the alkyl residue is attached to the rest of the molecule by a single bond. Whenever it appears herein, a numerical range such as “C1-6 alkyl” means that the alkyl group consists of 1 carbon atom, 2 carbon atoms, 3 carbon atoms, 4 carbon atoms, 5 carbon atoms or 6 carbon atoms, although the present definition also covers the occurrence of the term “alkyl” where no numerical range is designated. In some embodiments, the alkyl is a C1-10 alkyl, a C1-9 alkyl, a Ci-s alkyl, a C1-7 alkyl, a C1-6 alkyl, a C1-5 alkyl, a C1-4 alkyl, a C1-3 alkyl, a C1-2 alkyl, or a Ci alkyl.

[0028] Examples of alkyl groups include, but are not limited to, methyl, ethyl, n-propyl, isopropyl, 2- methyl-1 -propyl, 2-methyl-2-propyl, 2-methyl-l -butyl, 3 -methyl- 1 -butyl, 2-methyl-3-butyl, 2,2- dimethyl-1 -propyl, 2-methyl-l -pentyl, 3-methyl-l -pentyl, 4-methyl-l -pentyl, 2-methyl-2-pentyl, 3- methyl-2-pentyl, 4-methyl-2-pentyl, 2,2-dimethyl-l -butyl, 3, 3 -dimethyl- 1 -butyl, 2-ethyl-l -butyl, n-butyl, isobutyl, sec -butyl, t-butyl, n-pentyl, isopentyl, neopentyl, tert-amyl, and hexyl, and longer alkyl groups, such as heptyl, octyl, and the like.

[0029] Non-limiting examples of straight alkyl groups include methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, and decyl.

[0030] Branched alkyl groups include any straight alkyl group substituted with any number of alkyl groups. Non-limiting examples of branched alkyl groups include isopropyl, isobutyl, sec-butyl, and t- butyl.

[0031] When a carbon number limit is given at the beginning of a term which itself comprises two terms, the carbon number limitation is understood as inclusive for both terms. For example, for the term “Cy-uarylalkyl,” both the “aryl” and the “alkyl” portions of the term are included the carbon count, a maximum of 14 in this example, but additional substituent groups thereon are not included in the atom count unless they incorporate a carbon from the group’s designated carbon count, as in the “oxo” example above. Likewise when an atom number limit is given, for example “6-14 membered heteroarylalkyl,” both the “heteroaryl” and the “alkyl” portion are included the atom count limitation, but additional substituent groups thereon are not included in the atom count unless they incorporate a carbon from the group’s designated carbon count. As an example, the “alkyl” portion of, e.g. “Cv uarylalkyl” is meant to include alkylene, alkylidene or alkylidyne, unless stated otherwise, e.g. as in the terms “C7 uarylalkylene” or “Ce -loaryl-CEhCEh-.”

[0032] Unless stated otherwise specifically in the specification, an alkyl group is optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocyclylalkyl, heteroaryl, and the like. In some embodiments, the alkyl is optionally substituted with oxo, halogen, -CN, -CF3, -OH, -OMe, -NH2, or -NO2. In some embodiments, the alkyl is optionally substituted with oxo, halogen, -CN, -CF3, -OH, or -OMe. In some embodiments, the alkyl is optionally substituted with halogen. Non-limiting examples of substituted alkyl groups includes hydroxymethyl, chloromethyl, trifluoromethyl, aminomethyl, 1 -chloroethyl, 2-hydroxyethyl, 1,2-difluoroethyl, and 3- carboxypropyl.

[0033] “Alkenyl” refers to an optionally substituted straight-chain, or optionally substituted branched- chain hydrocarbon having one or more carbon-carbon double-bonds. The olefin or olefins of an alkenyl group can be, for example, E, Z, cis, trans, terminal, or e.w-rnelhylenc. An alkenyl group can be, for example, a C2, C3, C4, C5, Ce, C7. Cs, C9, C10, Cn, C12. C13, C14, C15, Cie, C17, Cis, C19, C20, C21, C22, C23, C24, C.25, C.26, C27, C.2S, C.29, C30, C.31, C32, C33, C34, C35, C.36, C37, C38, C,39, C.40, C4I, C.42, C43, C44, C,45, C46, C47, C48, C49, or C50 group that is substituted or unsubstituted. Non-limiting examples of alkenyl and alkenylene groups include ethenyl, prop-l-en-l-yl, isopropenyl, but-l-en-4-yl; 2-chloroethenyl, 4- hydroxybuten- 1 -yl, 7-hydroxy-7-methyloct-4-en-2-yl, and 7-hydroxy-7-methyloct-3,5-dien-2-yl.

[0034] Whenever it appears herein, a numerical range such as “C2-C6 alkenyl” means that the alkenyl group may consist of 2 carbon atoms, 3 carbon atoms, 4 carbon atoms, 5 carbon atoms, or 6 carbon atoms, although the present definition also covers the occurrence of the term “alkenyl” where no numerical range is designated. In some embodiments, the alkenyl is a C2-C10 alkenyl, a C2-C9 alkenyl, a C2-C8 alkenyl, a C2-C7 alkenyl, a C2-C6 alkenyl, a C2-C5 alkenyl, a C2-C4 alkenyl, a C2-C3 alkenyl, or a C2 alkenyl. Unless stated otherwise specifically in the specification, an alkenyl group is optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocyclylalkyl, heteroaryl, and the like. In some embodiments, an alkenyl is optionally substituted with oxo, halogen, -CN, -CF3, -OH, -OMe, -NH2, or -NO2. In some embodiments, an alkenyl is optionally substituted with oxo, halogen, -CN, -CF3, -OH, or -OMe. In some embodiments, the alkenyl is optionally substituted with halogen.

[0035] “Alkylene” refers to straight, branched and cyclic (and combinations thereof) divalent radical consisting solely of carbon and hydrogen atoms, containing no unsaturation and having from one to ten carbon atoms, for example, methylene, ethylene, propylene, n-butylene and the like. Alkylene refers to to the same residues as alkyl, but having two points of attachment and, specifically, being fully saturated. Examples of alkylene include ethylene (-CH2CH2-), propylene (-CH2CH2CH2-), dimethylpropylene (- CH2C(CH3)2CH2-), cyclohexan-l,4-diyl and the like. The term “alkylidene” and “alkylidyne” refer to straight, branched and cyclic (and combinations thereof) divalent radicals consisting solely of carbon and hydrogen atoms, and having at least one alkene or alkyne bond, respectively.

[0036] “Alkynyl” refers to an optionally substituted straight-chain or optionally substituted branched- chain hydrocarbon. The triple bond of an alkynyl group can be internal or terminal. An alkynyl or alkynylene group can be, for example, a C2, C3, C4, C5, C.6, C7, Cs, C9, C10, C11, C12, C13, C14, C15, Ci6, C17, C18, C19, C20, C2I, C22, C23, C24, C25, C26, C27, C28, C29, C30, C3I, C32, C33, C34, C35, C36, C37, C38, C39, C40, C41, C42, C43, C44, C45, C46, C47, C48, C49, or C50 group that is substituted or unsubstituted. Nonlimiting examples of alkynyl groups include ethynyl, prop-2-yn-l-yl, prop-l-yn- l-yl, and 2-methyl-hex- 4-yn-l-yl; 5-hydroxy-5-methylhex-3-yn-l-yl, 6-hydroxy-6-methylhept-3-yn-2-yl, and 5-hydroxy-5- ethylhept-3 -yn- 1 -yl .

[0037] Whenever it appears herein, a numerical range such as “C2-C6 alkynyl” means that the alkynyl group may consist of 2 carbon atoms, 3 carbon atoms, 4 carbon atoms, 5 carbon atoms, or 6 carbon atoms, although the present definition also covers the occurrence of the term “alkynyl” where no numerical range is designated. In some embodiments, the alkynyl is a C2-C10 alkynyl, a C2-C9 alkynyl, a C2-C8 alkynyl, a C2-C7 alkynyl, a C2-C6 alkynyl, a C2-C5 alkynyl, a C2-C4 alkynyl, a C2-C3 alkynyl, or a C2 alkynyl. Unless stated otherwise specifically in the specification, an alkynyl group is optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocyclylalkyl, heteroaryl, and the like. In some embodiments, an alkynyl is optionally substituted with oxo, halogen, -CN, -CF3, -OH, -OMe, -NHz, or -NO2. In some embodiments, an alkynyl is optionally substituted with oxo, halogen, -CN, -CF3, -OH, or -OMe. In some embodiments, the alkynyl is optionally substituted with halogen.

[0038] A haloalkyl group can be any alkyl group substituted with any number of halogen atoms, for example, fluorine, chlorine, bromine, and iodine atoms. A halo-alkenyl group can be any alkenyl group substituted with any number of halogen atoms. A haloalkynyl group can be any alkynyl group substituted with any number of halogen atoms.

[0039] An alkoxy group can be, for example, an oxygen atom substituted with any alkyl, alkenyl, or alkynyl group. An ether or an ether group comprises an alkoxy group. Non-limiting examples of alkoxy groups include methoxy, ethoxy, propoxy, isopropoxy, and isobutoxy.

[0040] The term "acyl" refers to the groups HC(0)-, alkyl-C(O)-, cycloalkyl-C(O)-, cycloalkenyl-C(O)-, aryl-C(O)-, heteroaryl-C(O)- and heterocyclyl-C(O)- where alkyl, cycloalkyl, cycloalkenyl, aryl, heteroaryl, and heterocyclyl are as described herein. By way of example acyl groups include acetyl and benzoyl groups. “Alkoxy” refers to a radical of the formula -ORawhere Rais an alkyl radical as defined. Unless stated otherwise specifically in the specification, an alkoxy group may be optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocyclylalkyl, heteroaryl, and the like. In some embodiments, an alkoxy is optionally substituted with oxo, halogen, -CN, -CF3, -OH, -OMe, -NH2, or -NO2. In some embodiments, an alkoxy is optionally substituted with oxo, halogen, -CN, -CF3, -OH, or -OMe. In some embodiments, the alkoxy is optionally substituted with halogen.

[0041] “Aminoalkyl” refers to an alkyl radical, as defined above, that is substituted by one or more amines. In some embodiments, the alkyl is substituted with one amine. In some embodiments, the alkyl is substituted with one, two, or three amines. Hydroxyalkyl include, for example, aminomethyl, aminoethyl, aminopropyl, aminobutyl, or aminopentyl. In some embodiments, the hydroxyalkyl is aminomethyl.

[0042] “Aryl” refers to a radical derived from a hydrocarbon ring system comprising hydrogen, 6 to 30 carbon atoms, and at least one aromatic ring. Hie aryl radical may be a monocyclic, bicyclic, tricyclic, or tetracyclic ring system, which may include fused (when fused with a cycloalkyl or heterocyclylalkyl ring, the aryl is bonded through an aromatic ring atom) or bridged ring systems. In some embodiments, the aryl is a 6- to 10-membered aryl. In some embodiments, the aryl is a 6-membered aryl. Aryl radicals include, but are not limited to, aryl radicals derived from the hydrocarbon ring systems of anthrylene, naphthylene, phenanthrylene, anthracene, azulene, benzene, chrysene, fluoranthene, fluorene, as- indacene, s-indacene, indane, indene, naphthalene, phenalene, phenanthrene, pleiadene, pyrene, and triphenylene. In some embodiments, the aryl is phenyl. Unless stated otherwise specifically in the specification, an aryl may be optionally substituted, for example, with halogen, amino, nitrile, nitro, hydroxyl, alkyl, alkenyl, alkynyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocyclylalkyl, heteroaryl, and the like. In some embodiments, an aryl is optionally substituted with halogen, methyl, ethyl, -CN, -CF3, -OH, -OMe, -NH2, or -NO2. In some embodiments, an aryl is optionally substituted with halogen, methyl, ethyl, -CN, -CF3, -OH, or -OMe. In some embodiments, the aryl is optionally substituted with halogen.

[0043] “Arylalkyl” or “Aralkyl” refers to a residue in which an aryl moiety is attached to a parent structure via one of an alkylene, alkylidene, or alkylidyne radical. Examples include benzyl, phenethyl, phenylvinyl, phenylallyl and the like. When specified as “optionally substituted,” both the aryl, and the corresponding alkylene, alkylidene, or alkylidyne portion of an arylalkyl group can be optionally substituted. By way of example, “C7-1 larylalkyf refers to an arylalkyl limited to a total of eleven carbons, e.g., a phenylethyl, a phenylvinyl, a phenylpentyl and a naphthylmethyl are all examples of a “C7 narylalkyl” group. “Cycloalkyl” refers to a stable, partially or fully saturated, monocyclic or polycyclic carbocyclic ring, which may include fused (when fused with an aryl or a heteroaryl ring, the cycloalkyl is bonded through a non-aromatic ring atom), bridged, or spiro ring systems. Representative cycloalkyls include, but are not limited to, cycloalkyls having from three to fifteen carbon atoms (C3-C15 cycloalkyl), from three to ten carbon atoms (C3-C10 cycloalkyl), from three to eight carbon atoms (C3-C8 cycloalkyl), from three to six carbon atoms (C3-C6 cycloalkyl), from three to five carbon atoms (C3-C5 cycloalkyl), or three to four carbon atoms (C3-C4 cycloalkyl). In some embodiments, the cycloalkyl is a 3- to 6-membered cycloalkyl. In some embodiments, the cycloalkyl is a 5- to 6-membered cycloalkyl. Non-limiting examples of cycloalkyl groups include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl groups. Cycloalkyl groups also include fused-, bridged-, and spiro-bicycles and higher fused-, bridged-, and spiro-systems. A cycloalkyl group can be substituted with any number of straight, branched, or cyclic alkyl groups. Non-limiting examples of cyclic alkyl groups include cyclopropyl, 2- methyl-cycloprop-l-yl, cycloprop-2-en-l-yl, cyclobutyl, 2,3-dihydroxycyclobut-l-yl, cyclobut-2-en-l-yl, cyclopentyl, cyclopent-2-en- 1 -yl, cyclopenta-2,4-dien-l-yl, cyclohexyl, cyclohex-2-en-l-yl, cycloheptyl, cyclooctanyl, 2,5 -dimethylcyclopent- 1-yl, 3,5-dichlorocyclohex-l-yl, 4-hydroxycyclohex- 1 -yl, 3,3,5- trimethylcyclohex-1 -yl, octahydropentalenyl, octahydro- 1 / / -indenyl, 3a,4,5,6,7,7a-hexahydro-3 / / -inden- 4-yl, decahydroazulenyl, bicyclo- [2. l.l]hexanyl, bicyclo[2.2.1]heptanyl, bicyclo [3. l.l]heptanyl, 1,3- dimethyl[2.2.1]heptan-2-yl, bicyclo[2.2.2]octanyl, and bicyclo[3.3.3]undecanyl.

[0044] Monocyclic cycloalkyls include, for example, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl.

[0045] Polycyclic cycloalkyls or carbocycles include, for example, adamantyl, norbomyl, decalinyl, bicyclo[3.3.0]octane, bicyclo[4.3.0]nonane, cis-decalin, trans-decalin, bicyclo[2.1.1]hexane, bicyclo[2.2.1]heptane, bicyclo[2.2.2]octane, bicyclo[3.2.2]nonane, and bicyclo[3.3.2]decane, and 7,7-dimethyl-bicyclo|2.2.1 lheptanyl.

[0046] Partially saturated cycloalkyls include, for example, cyclopentenyl, cyclohexenyl, cycloheptenyl, and cyclooctenyl. Unless stated otherwise specifically in the specification, a cycloalkyl is optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, alkyl, alkenyl, alkynyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocyclylalkyl, heteroaryl, and the like. In some embodiments, a cycloalkyl is optionally substituted with oxo, halogen, methyl, ethyl, -CN, -CF3, -OH, -OMe, -NH2, or - NO2. In some embodiments, a cycloalkyl is optionally substituted with oxo, halogen, methyl, ethyl, -CN, -CF3, -OH, or -OMe. In some embodiments, the cycloalkyl is optionally substituted with halogen.

[0047] “Deuteroalkyl” refers to an alkyl radical, as defined above, that is substituted by one or more deuteriums. In some embodiments, the alkyl is substituted with one deuterium. In some embodiments, the alkyl is substituted with one, two, or three deuteriums. In some embodiments, the alkyl is substituted with one, two, three, four, five, or six deuteriums. Deuteroalkyl include, for example, CD3, CH2D, CHD2, CH2CD3, CD2CD3, CHDCD3, CH2CH2D, or CH2CHD2. In some embodiments, the deuteroalkyl is CD .

[0048] “Haloalkyl” refers to an alkyl radical, as defined above, that is substituted by one or more halogens. In some embodiments, the alkyl is substituted with one, two, or three halogens. In some embodiments, the alkyl is substituted with one, two, three, four, five, or six halogens. Haloalkyl include, for example, trifluoromethyl, difluoromethyl, fluoromethyl, trichloromethyl, 2,2,2-trifluoroethyl, 1 ,2-difluoroethyl, 3-bromo-2-fluoropropyl, 1,2-dibromoethyl, and the like. In some embodiments, the haloalkyl is trifluoromethyl.

[0049] “Halo” or “halogen” refers to bromo, chloro, fluoro, or iodo. In some embodiments, halogen is fluoro or chloro. In some embodiments, halogen is fluoro.

[0050] “Heteroalkyl” refers to an alkyl group in which one or more skeletal atoms of the alkyl are selected from an atom other than carbon, e.g., oxygen, nitrogen (e.g., -NH-, -N(alkyl)-), sulfur, or combinations thereof. A heteroalkyl is attached to the rest of the molecule at a carbon atom of the heteroalkyl. In one aspect, a heteroalkyl is a C 1-6 heteroalkyl wherein the heteroalkyl is comprised of 1 to 6 carbon atoms and one or more atoms other than carbon, e.g., oxygen, nitrogen (e.g. -NH-, -N(alkyl)-), sulfur, or combinations thereof wherein the heteroalkyl is attached to the rest of the molecule at a carbon atom of the heteroalkyl. Examples of such heteroalkyl are, for example, - CH2OCH3, -CH2CH2OCH3, -CH2CH2OCH2CH2OCH3, or -CH(CH3)OCH3. Unless stated otherwise specifically in the specification, a heteroalkyl is optionally substituted for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, alkyl, alkenyl, alkynyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocyclylalkyl, heteroaryl, and the like. In some embodiments, a heteroalkyl is optionally substituted with oxo, halogen, methyl, ethyl, -CN, -CF3, -OH, -OMe, -NHz, or -NO2. In some embodiments, a heteroalkyl is optionally substituted with oxo, halogen, methyl, ethyl, -CN, -CF3, -OH, or -OMe. In some embodiments, the heteroalkyl is optionally substituted with halogen.

[0051] “Hydroxyalkyl” refers to an alkyl radical, as defined above, that is substituted by one or more hydroxyls. In some embodiments, the alkyl is substituted with one hydroxyl. In some embodiments, the alkyl is substituted with one, two, or three hydroxyls. Hydroxyalkyl include, for example, hydroxymethyl, hydroxyethyl, hydroxypropyl, hydroxybutyl, or hydroxypentyl. In some embodiments, the hydroxyalkyl is hydroxymethyl.

[0052] A heterocycle can be any ring containing a ring atom that is not carbon, for example, N, O, S, P, Si, B, or any other heteroatom. A heterocycle can be substituted with any number of substituents, for example, alkyl groups and halogen atoms. A heterocycle can be aromatic (heteroaryl) or non-aromatic. Non-limiting examples of heterocycles include pyrrole, pyrrolidine, pyridine, pyrimidine, pyrazine, pyridazine, piperidine, succinimide, maleimide, morpholine, imidazole, thiophene, furan, tetrahydrofuran, pyran, and tetrahydropyran.

[0053] “Heterocyclyl” refers to a stable 3- to 24-membered heterocycle. Non-limiting examples of heterocycles include: heterocyclic units having a single ring containing one or more heteroatoms, nonlimiting examples of which include, diazirinyl, aziridinyl, azetidinyl, pyrazolidinyl, imidazolidinyl, oxazolidinyl, isoxazolinyl, thiazolidinyl, isothiazolinyl, oxathiazolidinonyl, oxazolidinonyl, hydantoinyl, tetrahydrofuranyl, pyrrolidinyl, morpholinyl, piperazinyl, piperidinyl, dihydropyranyl, tetrahydropyranyl, piperidin-2-onyl, 2,3,4,5-tetrahydro- IH-azepinyl, 2,3-dihydro- 1 / / -indole, and 1, 2,3,4- tetrahydroquinoline; and ii) heterocyclic units having 2 or more rings one of which is a heterocyclic ring, non-limiting examples of which include hexahydro- IH-pyrrolizinyl, 3a,4,5,6,7,7a-hexahydro-lH- benzo[d]imidazolyl, 3a,4,5,6,7,7a-hexahydro-lH-indolyl, 1,2,3,4-tetrahydroquinolinyl, and decahydro- 1 H-cycloocta[b]pyrrolyl.

[0054] “Heterocyclylalkyl” refers to a heterocyclyl group that is partially or fully saturated. Accordingly, heterocyclylalkyl refers to a stable 3- to 24-membered partially or fully saturated ring radical comprising 2 to 23 carbon atoms and from one to 8 heteroatoms selected from the group consisting of nitrogen, oxygen, phosphorous, and sulfur. Unless stated otherwise specifically in the specification, the heterocyclylalkyl radical may be a monocyclic, bicyclic, tricyclic, or tetracyclic ring system, which may include fused (when fused with an aryl or a heteroaryl ring, the heterocyclylalkyl is bonded through a non-aromatic ring atom) or bridged ring systems; and the nitrogen, carbon, or sulfur atoms in the heterocyclylalkyl radical may be optionally oxidized; the nitrogen atom may be optionally quatemized.

[0055] Representative heterocyclylalkyls include, but are not limited to, heterocyclylalkyls having from two to fifteen carbon atoms (C2-C15 heterocyclylalkyl), from two to ten carbon atoms (C2-C10 heterocyclylalkyl), from two to eight carbon atoms (C2-C8 heterocyclylalkyl), from two to six carbon atoms (C2-C6 heterocyclylalkyl), from two to five carbon atoms (C2-C5 heterocyclylalkyl), or two to four carbon atoms (C2-C4 heterocyclylalkyl). In some embodiments, the heterocyclylalkyl is a 3- to 6- membered heterocyclylalkyl. In some embodiments, the cycloalkyl is a 5- to 6-membered heterocyclylalkyl. Examples of such heterocyclylalkyl radicals include, but are not limited to, aziridinyl, azetidinyl, dioxolanyl, thienyl[l,3]dithianyl, decahydroisoquinolyl, imidazolinyl, imidazolidinyl, isothiazolidinyl, isoxazolidinyl, morpholinyl, octahydroindolyl, octahydroisoindolyl, 2-oxopiperazinyl, 2-oxopiperidinyl, 2-oxopyrrolidinyl, oxazolidinyl, piperidinyl, piperazinyl, 4-piperidonyl, pyrrolidinyl, pyrazolidinyl, quinuclidinyl, thiazolidinyl, tetrahydrofuryl, trithianyl, tetrahydropyranyl, thiomorpholinyl, thiamorpholinyl, 1-oxo-thiomorpholinyl, 1,1-dioxo-thiomorpholinyl, 1,3-dihydroisobenzofuran-l-yl, 3- oxo-l,3-dihydroisobenzofuran-l-yl, methyl-2-oxo-l,3-dioxol-4-yl, and 2-oxo-l,3-dioxol-4-yl. The term heterocyclylalkyl also includes all ring forms of the carbohydrates, including but not limited to, the monosaccharides, the disaccharides, and the oligosaccharides. It is understood that when referring to the number of carbon atoms in a heterocyclylalkyl, the number of carbon atoms in the heterocyclylalkyl is not the same as the total number of atoms (including the heteroatoms) that make up the heterocyclylalkyl (i.e. skeletal atoms of the heterocyclylalkyl ring). Unless stated otherwise specifically in the specification, a heterocyclylalkyl is optionally substituted, for example, with oxo, halogen, amino, nitrile, nitro, hydroxyl, alkyl, alkenyl, alkynyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocyclylalkyl, heteroaryl, and the like. In some embodiments, a heterocyclylalkyl is optionally substituted with oxo, halogen, methyl, ethyl, -CN, -CF3, -OH, -OMe, -NH2, or -NO2. In some embodiments, a heterocyclylalkyl is optionally substituted with oxo, halogen, methyl, ethyl, -CN, -CF3, -OH, or -OMe. In some embodiments, the heterocyclylalkyl is optionally substituted with halogen.

[0056] “Heteroaryl” refers to a 5- to 14- membered ring system radical comprising hydrogen atoms, one to thirteen carbon atoms, one to six heteroatoms selected from the group consisting of nitrogen, oxygen, phosphorous, and sulfur, and at least one aromatic ring, he heteroaryl radical may be a monocyclic, bicyclic, tricyclic, or tetracyclic ring system, which may include fused (when fused with a cycloalkyl or heterocyclylalkyl ring, the heteroaryl is bonded through an aromatic ring atom) or bridged ring systems; and the nitrogen, carbon, or sulfur atoms in the heteroaryl radical may be optionally oxidized; the nitrogen atom may be optionally quaternized. In some embodiments, the heteroaryl is a 5- to 10- membered heteroaryl. In some embodiments, the heteroaryl is a 5- to 6-membered heteroaryl. Examples include, but are not limited to, azepinyl, acridinyl, benzimidazolyl, benzothiazolyl, benzindolyl, benzodioxolyl, benzofuranyl, benzoox azolyl, benzothiazolyl, benzothiadiazolyl, benzo[b][l,4]dioxepinyl, 1 ,4-benzodioxanyl, benzonaphthofuranyl, benzoxazolyl, benzodioxolyl, benzodioxinyl, benzopyranyl, benzopyranonyl, benzofuranyl, benzofuranonyl, benzothienyl (benzothiophenyl), benzotriazolyl, benzo[4,6|imidazo| l,2-a|pyridinyl, carbazolyl, cinnolinyl, dibenzofuranyl, dibenzothiophenyl, furanyl, furanonyl, isothiazolyl, imidazolyl, indazolyl, indolyl, indazolyl, isoindolyl, indolinyl, isoindolinyl, isoquinolyl, indolizinyl, isoxazolyl, naphthyridinyl, oxadiazolyl, 2-oxoazepinyl, oxazolyl, oxiranyl, 1- oxidopyridinyl, 1 -oxidopyrimidinyl, 1 -oxidopyrazinyl, 1 -oxidopyridazinyl, 1 -phenyl- IH-pyrrolyl, phenazinyl, phenothiazinyl, phenoxazinyl, phthalazinyl, pteridinyl, purinyl, pyrrolyl, pyrazolyl, pyridinyl, pyrazinyl, pyrimidinyl, pyridazinyl, quinazolinyl, quinoxalinyl, quinolinyl, quinuclidinyl, isoquinolinyl, tetrahydroquinolinyl, thiazolyl, thiadiazolyl, triazolyl, tetrazolyl, triazinyl, and thiophenyl (i.e., thienyl). Unless stated otherwise specifically in the specification, a heteroaryl is optionally substituted, for example, with halogen, amino, nitrile, nitro, hydroxyl, alkyl, alkenyl, alkynyl, haloalkyl, alkoxy, aryl, cycloalkyl, heterocyclylalkyl, heteroaryl, and the like. In some embodiments, a heteroaryl is optionally substituted with halogen, methyl, ethyl, -CN, -CF3, -OH, -OMe, -NH2, or -NO2. In some embodiments, a heteroaryl is optionally substituted with halogen, methyl, ethyl, -CN, -CF3, -OH, or -OMe. In some embodiments, the heteroaryl is optionally substituted with halogen.

[0057] II. Compounds

[0058] In one embodiment enhancers of pesticidal activity disclosed herein include those having the Formulas set forth below. In one embodiment, the present disclosure provides a method for inhibiting apyrase, comprising contacting the apyrase with a compound of Formula (I) or an agriculturally acceptable salt, solvate and / or N-oxide thereof, wherein

[0059] Z1and Z2are each independently selected from a group consisting of hydrogen, C1-6 alkyl; or Z1together with Z2and the atoms to which Z1and Z2are attached, forms a 5- or 6-membered ring optionally substituted with one or more of Ra; wherein the 5- or 6-membered ring is optionally a heterocyclyl ring with one or more heteroatom groups selected from O, N, -N(Re)-, S, -S(O)-, -SO2-;

[0060] R1is independently selected from a group consisting of hydrogen, Ci-6 alkyl, optionally substituted with one or more Ra;

[0061] R2is selected from hydrogen and C1-6 alkyl;

[0062] X is -(CRaRb)n-Y;

[0063] Y is selected from the group consisting of Ra, Rb, Rasubstituted with one or more of the same or different Rs, Raor Rb, -ORasubstituted with one or more of the same or different Raor Rb; -S(O)Rs, - S(O)2RS, -N(Rd)S(O)2Rs, -S(O)NRCRC, -S(O)2-NRCRC, -OS(O)Rd, -OS(O)2Rd, -OS(O)2ORd, -C(O)OR8, -C(O)R8, -OC(O)R8, -C(O)NRCRC, - NRCRC, -N(Rd)-C(0)R8, -N(Rd)-C(O)OR8, N(Rd)-C(0)NRcRc, -SR8, -(CH2)mR8, -OC(O)-(CH2)m-C(O)R8, -CHRCRC;

[0064] R8is selected from the group consisting of Ra, Rh, Rasubstituted with one or more of the same or different Raor Rb, -CH2Rasubstituted with one or more of the same or different Raor Rb, -ORasubstituted with one or more of the same or different Raor Rb; each Rais independently selected from hydrogen, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 haloalkyl, C3-8 cycloalkyl, Ce-io aryl, C5-10 heteroaryl, Ce-i6 arylalkyl, 2-6 membered heteroalkyl and 3-8 membered heterocyclylalkyl; Rbis independently selected from the group consisting of =0, -0Ra, halogen, C1-3 haloalkyloxy, -OCF3, =S, -SRd, =NRd, =N0Rd, -NRCRC, -SF5, halogen, -CF3, -CN, -NO2, -S(O)Rd, -S(O)2Rd, -S(O)2ORd, -N(H)S(0)2Rd, -S(O)NRCRC, -S(O)2NRCRC, -OS(O)Rd, -OS(O)2Rd, -OS(O)2ORd, -0S(0)2NRCRC, -C(O)Rd, -C(O)ORd, -C(O)NRCRC, -C(NH)NRCRC, -C(NRa)NRcRc, -C(N0H)Ra, -C(NOH)NRCRC, -0C(0)Rd, -0C(0)0Rd, -0C(0)NRcRc, -OC(NH)NRCRC, -0C(NRa)NRcRc, -[NHC(0)]„Rd, -[NRaC(0)]„Rd, -[NHC(O)];!ORd, -[NRaC(0)]„0Rd, -[NHC(O)]„NRCRC, -[NRaC(O)]„NRcRc, -[NHC(NH)]„NRCRCand -[NRaC(NRa)]„NRcRc; each Rcis hydrogen, R8, or, alternatively, two Rcare taken together with the atom to which they are bonded to form a 5 to 10-membered cycloalkyl or heterocyclylalkyl which may optionally be substituted with one or more of the same or different Regroups; each Rdis independently hydrogen or C1-6 alkyl; each Reis independently Rbor Rd; each m is independently an integer from 0 to 2; and each n is independently an integer from 0 to 2; provided that the compound is not

[0065] In one embodiment of compounds according to Formula (I), R1and R2independently are selected from hydrogen and C1-6 alkyl. In certain embodiments, R1is C1-6 alkyl optionally substituted with one or more Ra. In one embodiment of such compounds according to Formula (I) R2is hydrogen. In another embodiment of such compounds according to Formula (I) R1is C1-6 alkyl optionally substituted with one or more Raand R2is hydrogen.

[0066] In one embodiment of the enhancer compounds according to Formula (I), the compound has the formula:

[0067] In another embodiment of the enhancer compounds according to Formula (I), the compound has the formula:

[0068] In certain embodiments of enhancer compounds according to Formulas (I), (la) and (lb) at least one of Z1and Z2is hydrogen, such as wherein Z1is hydrogen, Z2is hydrogen, or both Z1and Z2are hydrogen. In one embodiment, at least one of Z1and Z2is Ci-6 alkyl, such as wherein Z1is Ci-6 alkyl, Z2is Ci-6 alkyl, or both Z1and Z2are the same or different Ci-6 alkyl.

[0069] In other embodiments of enhancer compounds according to Formulas (I), (la) and (lb), Z1and Z2together form a 5- or 6-membered aliphatic, aromatic, heteroaliphatic or heteroaromatic ring optionally substituted with one or more R8. In one embodiment, Z1and Z2together form a 5- or 6-membered aliphatic or heteroaliphatic ring. In certain embodiments, Z1and Z2together form an aliphatic ring, and in one such embodiment, enhancer compounds of Formula (I) have Formula (lai): (lai), wherein R1, R2and X are as set forth above with respect to Formula (I).

[0070] In other embodiments wherein Z1and Z2together form an aliphatic ring, enhancer compounds of Formula (I) have Formula (Ibl): wherein R1, R2and X are as set forth above with respect to Formula (I).

[0071] In other embodiments of compounds according to Formula (I), Z1and Z2together form a 5- or 6- membered aromatic or heteroaromatic ring. In one embodiment, Z1and Z2together form an aromatic ring, and in a particular embodiment, such compounds according to Formula (I) are represented by Formula (Ia2): wherein R1, R2and X are as set forth above with respect to Formula (I).

[0072] In other embodiments wherein Z1and Z2together form an aromatic ring, enhancer compounds of Formula (I) have Formula (Ib2): wherein R1, R2and X are as set forth above with respect to Formula (I).

[0073] In other embodiments of compounds according to Formula (I), Z1and Z2together form a 5- or 6- mcmbcrcd hctcroaromatic ring. In one embodiment, Z1and Z2together form a 6-mcmbcrcd heteroaromatic ring, and in a particular embodiment, such compounds according to Formula (I) are represented by Formula (Ia3): wherein R1, R2and X are as set forth above with respect to Formula (I).

[0074] In other embodiments wherein Z1and Z2together form a heteroaromatic ring, enhancer compounds of Formula (I) have Formula (Ib2): wherein R1, R2and X are as set forth above with respect to Formula (I).

[0075] In one embodiment, Z1and Z2together form a 5- or 6-membered heteroaliphatic ring. In certain embodiments, Z1and Z2together form a six-membered heteroaliphatic ring, and in certain such embodiments, enhancer compounds of Formula (I) have a Formula (Ia4), (Ia5) or (Ia6): wherein R1, R2, X and Reare as set forth above with respect to Formula (I).

[0076] In other embodiments wherein Z1and Z2together form a heteroaliphatic ring, enhancer compounds of Formula (I) have Formula (Ib4), (Ib5) or (Ib6): wherein R1, R2, X and Reare as set forth above with respect to Formula (I).

[0077] In one embodiment wherein Z1together with Z2and the atoms to which Z1and Z2are attached, forms a 5- or 6-mcmbcrcd ring, the ring is substituted with one or more of Raand Rb. Certain examples of such substituted rings include compounds having Formulas (Ia7) and (Ib7): wherein R1, R2, X and Reare as set forth above with respect to Formula (I).

[0078] In certain embodiments of Formulas (I), (la), (lb), (lai), (Ibl), (Ia2), (Ib2), (Ia3), (Ib3), (Ia4), (Ib4), (Ia5), (Ib5), (Ia6), (Ib6), (Ia7) and (Ib7), X is -(CRaRb)n-Y, wherein Ra, Rb, and X are as set forth with respect to Formula (I), and Y is selected from the group consisting of:

[0079] Specific examples of apyrase inhibitors according to the present disclosure, including compounds of Formulas (I), (la), (lb), (lai), (Ibl), (la2), (lb2), (la3), (Ib3), (Ia4), (lb4), (la5), (lb5), (Ia6), (Ib6), (la7) and / or (Ib7), for use to enhance the activity of an agricultural or horticultural pesticide as described herein, are illustrated below in Table 1:

[0080]

[0081] Additional specific examples of apyrase inhibitors according to the present disclosure, including compounds of Formulas (I), (la), (lb), (lai), (Ibl), (Ia2), (Ib2), (Ia3), (Ib3), (Ia4), (Ib4), (Ia5), (Ib5), (Ia6), (Ib6), (Ia7) and / or (Ib7), for use to enhance the activity of an agricultural or horticultural pesticide as described herein, are illustrated below in Table 2: III. Target Crops and their Pathogens

[0082] The present disclosure provides formulations and methods for their use in treating crops for pathogens. In one embodiment, a disclosed compound, such as a compound of Formulas (I), (la), (lb), (lai), (Ibl), (Ia2), (Ib2), (Ia3), (Ib3), (Ia4), (Ib4), (Ia5), (Ib5), (Ia6), (Ib6), (Ia7) and / or (Ib7), is administered in combination with an agricultural or horticultural pesticide, such as an acaricide, antimicrobial, fungicide, herbicide, insecticide, molluscicide and / or nematocide. Crops that can be treated, include those plagued by various pathogens, including without limitation, bacteria, viruses, fungal pathogens, mites, nematodes, molluscs, weeds or other pests, as is known to those of ordinary skill in the agricultural arts. By way of example, such agricultural and horticultural crops that can be treated according to the present disclosure include plants, whether genetically modified or not, including their harvested products, such as: cereals; vegetables; root crops; potatoes; trees such as fruit trees, for example banana trees, tea, coffee trees, or cocoa trees; grasses; lawn grass; or cotton.

[0083] Windsor and coworkers describe the compound: , ethyl 2-(2-(cyclohexylamino)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate, referred to herein as “Windsor compound XVI,” as enhancing the ability of certain fungicides to inhibit the growth of different plant-pathogenic fungi (WO 2006 / 0276339). The present compounds surprisingly enhance the ability of a variety of pesticides against a broad variety of pathogens, including fungal pathogens. In addition, examples of the presently disclosed compound exhibit superior enhancer activity than Windsor compound XVI.

[0084] The agricultural or horticultural enhancer disclosed herein may be applied to each part of plants, such as leaves, stems, patterns, flowers, buds, fruits, seeds, sprouts, roots, tubers, tuberous roots, shoots, or cuttings. The agricultural or horticultural enhancer according to the present disclosure may also be applied to improved varieties, cultivars, as well as mutants, hybrids and genetically modified embodiments of these plants.

[0085] The agricultural or horticultural treatment described herein may be used to conduct seed treatment, foliage application, soil application, or water application, so as to control various diseases occurring in agricultural or horticultural crops, including flowers, lawns, and pastures.

[0086] The present compounds are useful for potentiating the effects of antimicrobial agents. For example, the present compounds can be used in combination with an antimicrobial agent to combat bacterial and viral infection. The present compounds are useful for potentiating the effects of herbicides. For example, the present compounds can be used in combination with one or more herbicide to control weeds or other unwanted vegetation.

[0087] The present compounds are useful for potentiating the effects of insecticides. For example, the present compounds can be used in combination with one or more insecticide to control insect infestation. The present compounds are useful for potentiating the effects of acaricides or miticides. For example, the present compounds can be used in combination with one or more acaricidal agent to control mites. The present compounds are useful for potentiating the effects of molluscicides. For example, the present compounds can be used in combination with one or more molluscicide to prevent interference of slugs or snails with a crop.

[0088] The present compounds are useful for potentiating the effects of nematocides. For example, the present compounds can be used in combination with one or more nematocide to prevent interference of nematodes with a crop.

[0089] The present compounds are particularly useful for potentiating the effects of fungicides against plant fungal pathogens. Examples of pathogens treated according to the present disclosure include, without limitation, Botrytis cinerea, Colletotrichum graminicola, Fusarium oxysporurn, Sclerotiana sclerotiorum, Verticillium dahlia, Mycospharella gramincola and Sphacelotheca reliana.

[0090] Botrytis cinerea is an airborne plant pathogen with a necrotrophic lifestyle attacking over 200 crop hosts worldwide. It mainly attacks dicotyledonous plant species, including important protein, oil, fiber and horticultural crops, grapes and strawberries and also Botrytis also causes secondary soft rot of fruits and vegetables during storage, transit and at the market. Many classes of fungicides have failed to control Botrytis cinerea due to its genetic plasticity.

[0091] The genus Colletotrichum comprises -600 species attacking over 3,200 species of monocot and dicot plants. Colletotrichum graminicola primarily infects maize (Zea mays), causing annual losses of approximately 1 billion dollars in the United States alone (Connell et al., 2012).

[0092] Fusarium wilt of banana, caused by the soil-borne fungus Fusarium oxysporurn f.sp. cubense, is a major threat to banana production worldwide. No fungicides are currently available to effectively control the disease once plants are infected (Peng J et al., 2014).

[0093] The white mold fungus Sclerotinia sclerotiorum is known to attack more than 400 host species and is considered one of the most prolific plant pathogens. The majority of the affected crop species are dicotyledonous, along with a number of agriculturally significant monocotyledonous plants. Some important crops affected by . sclerotiorum include legumes (soybean), most vegetables, stone fruits and tobacco. The ascomycete Verticillium dahliae is a soil-borne fungal plant pathogen that causes vascular wilt diseases in a broad range of dicotyledonous host species. V. dahliae can cause severe yield and quality losses in cotton and other important crops such as vegetables, fibers, fruit, nut trees, forest trees and ornamental plants.

[0094] The ascomycete fungus Mycospharella gramincola (anamorph: Seploria trilici) is one of the most important foliar diseases of wheat leaves, occurring wherever wheat is grown. Yield losses attributed to this disease range from 25%-50%, and are especially high in Europe, the Mediterranean region and East Africa. Infection by M. gramincola is initiated by air borne ascopores produced on residues of last season's crop. Primary infection usually occurs after seedlings emerge in spring or fall. The mature disease is characterized by necrotic lesions on the leaves and stems of infected plants.

[0095] The basidiomycete fungus Sphacelotheca reliana infects corn (Zea mays)' systemically, causing Head Smut. Yield loss attributed to the disease is variable, and is directly dependent on the incidence of the disease. The fungus overwinters as diploid teliospores in crop debris or soil. Floral structures are converted to sori containing masses of powdery teliospores that resemble mature galls of common smut.

[0096] Examples of crops to be treated and plant diseases (pathogens) to be controlled using the presently disclosed compounds and compositions include, without limitation:

[0097] Sugar beet: brown spot disease (Cercospora beticola), black root disease (Aphanomyces cochlioides), root rot disease (Thanatephorus cucumeris), leaf rot disease (Thanatephorus cucumeris), and the like.

[0098] Peanut: brown spot disease (Mycosphaerella arachidis), leaf mold (Ascochyta sp.), rust disease (Puccinia arachidis), damping-off disease (Pythium debaryanum), rust spot disease (Alternaria alternate), stem rot disease (Sclerotium rolfsii), black rust disease (Mycosphaerella berkeleyi), and the like.

[0099] Cucumber: powdery mildew (Sphaerothecafuliginea), downy mildew (Pseudoperonospora cubensis), gummy stem blight (Mycosphaerella melonis), wilt disease (Fusarium oxysporum), sclerotinia rot (Sclerotinia sclerotiorum), gray mold Botrytis cinerea), anthracnose (Colletotrichum orbiculare), scab (Cladosporium cucumerinuir), brown spot disease (Corynespora cassiicola), damping-off disease (Pythium debaryanum, Rhizoctonia solani Kuhn), Phomopsis root rot disease (Phomopsis sp.), Bacterial spot (Pseudomonas syringae pv. Lechrymans), and the like.

[0100] Tomato: gray mold disease (Botrytis cinerea), leaf mold disease (Cladosporium fulvum), late blight disease (Phytophthora infestans), Verticillium wilt disease (Verticillium albo-atrum, Verticillium dahliae), powdery mildew disease (Oidium neolycopersici), early blight disease (Alternaria solani), leaf mold disease (Pseudocercospora fuligena), and the like.

[0101] Eggplant: gray mold disease (Botry tis cinerea), black rot disease (Corynespora melongenae), powdery mildew disease (Erysiphe cichoracearum), leaf mold disease (Mycovellosiella nattrassii). sclerotinia rot disease (Sclerotinia sclerotiorum), Verticillium wilt disease (V erticillium dahlia), Mycosphaerella blight (Phomopsis vexans), and the like.

[0102] Strawberry: gray mold disease (Botrytis cinerea , powdery mildew disease (Sphaerotheca h muli'), anthracnose disease (Colletotrichum aculalum, Colletotrichum fragariae), phytophthora rot disease (Phytophthora cactorum), soft rot disease (Rhizopus stolonifer), fusarium wilt disease (Fusarium oxysporum), verticillium wilt disease (Verticillium dahlia), and the like.

[0103] Onion: neck rot disease (Botrytis allii), gray mold disease (Botrytis cinerea , leaf blight disease (Botrytis squamosa), downy mildew disease (Peronospora destructor , Phytophthora pom disease (Phytophthora porn), and the like.

[0104] Cabbage: clubroot disease (Plasmodiophora brassicae), soft rot disease (Erwinia carotovora), black rot disease (Xanthomonas campesrtis pv. campestris), bacterial black spot disease (Pseudomonas syringae pv. Maculicola, P.s. pv. alisalensis), downy mildew disease (Peronospora parasitica), sclerotinia rot disease (Sclerotinia sclerotiorum), black spot disease (Alternaria brassicicola), gray mold disease (Botrytis cinerea), and the like.

[0105] Common bean: sclerotinia rot disease (Sclerotinia sclerotiorum , gray mold disease (Botrytis cinerea), anthracnose (Colletotrichum lindemuthianum), angular spot disease (Phaeoisariopsis griseola), and the like.

[0106] Apple: powdery mildew disease (Podosphaera leucotricha), scab disease (Venturia inaequalis), Monilinia disease (Monilinia mali), black spot disease (Mycosphaerella pomi), valla canker disease (Valsa mali), alternaria blotch disease (Alternaria mali), rust disease (Gymnosporangium yamadae), ring rot disease (Botryosphaeria berengeriana), anthracnose disease (Glomerella cingulata, Colletotrichum acutatum), leaf rot disease (Diplocarpon mali), fly speck disease (Zygophiala jamaicensis). Sooty blotch (Gloeodes pomigena), violet root rot disease (Helicobasidium mompa), gray mold disease (Botrytis cinerea), and the like.

[0107] Japanese apricot: scab disease (Cladosporium carpophilum), gray mold disease (Botrytis cinerea), brown rot disease (Monilinia mumecola), and the like.

[0108] Persimmon: powdery mildew disease (Phyllactinia kakicola), anthracnose disease (Gloeosporium kaki), angular leaf spot (Cercospora kaki), and the like.

[0109] Peach: brown rot disease (Monilinia fructicola), scab disease (Cladosporium carpophilum), phomopsis rot disease (Phomopsis sp.), bacterial shot hole disease (Xanthomonas campestris pv. pruni), and the like.

[0110] Almond: brown rot disease (Monilinia taxa), spot blotch disease (Stigmina carpophila , scab disease (Cladosporium carpophilum), red leaf spot disease (Polystigma rubrum), alternaria blotch disease (Aliernaria alternata), anthracnose (Colletotrichum gloeospoides), and the like.

[0111] Yellow peach: brown rot disease (Monilinia fructicola), anthracnose disease (Colletotrichum acutatum), black spot disease (Alternaria sp.), Monilinia kusanoi disease (Monilinia kusanoi , and the like.

[0112] Grape: gray mold disease (Botrytis cinerea), powdery mildew disease (Uncinula necator), ripe rot disease (Glomerella cingulata, Colletotrichum acutatum), downy mildew disease (Plasmopara viticola), anthracnose disease (Elsinoe ampelina), brown spot disease (Pseudocercospora vitis), black rot disease (Guignardia bidwellii), white rot disease (Coniella castaneicola), rust disease (Phakopsora ampelopsidis), and the like.

[0113] Pear: scab disease ( Venturia nashicola), rust disease (Gymnosporangium asiaticum), black spot disease (Alternaria kikuchiana), ring rot disease (Botryosphaeria berengeriana), powdery mildew disease (Phyllactinia mali), Cytospora canker disease (Phomopsis fukushii), brown spot blotch disease (Stemphylium vesicariuni), anthracnose disease (Glomerella cingulata), and the like.

[0114] Tea: ring spot disease (Pestalotiopsis longiseta, P. theae), anthracnose disease (Colletotrichum theae-sinensis), Net blister blight (Exobasidium reticulatum), and the like.

[0115] Citrus fruits: scab disease (Elsinoe fawcettii), blue mold disease (Penicillium italicum), common green mold disease (Penicillium digitatum), gray mold disease (Botrytis cinerea), melanose disease (Diaporthe citri), canker disease (Xanthomonas campestris pv. Citri), powdery mildew disease (Oidium sp.), and the like.

[0116] Wheat: powdery mildew (Blumeria graminisf. sp. tritici), red mold disease (Gibberella zeae), brown rust disease (Puccinia recondita), brown snow mold disease (Pythium iwayamai), pink snow mold disease (Monographella nivalis), eye spot disease (Pseudocercosporella herpotrichoides), leaf scorch disease (Septoria tritici), glume blotch disease (Leptosphaeria nodorum), typhula snow blight disease (Typhula incarnata), sclerotinia snow blight disease (Myriosclerotinia borealis), damping-off disease (Gaeumannomyces graminis), ergot disease (Claviceps purpurea), stinking smut disease (Tilletia caries), loose smut disease (Ustilago nuda), and the like.

[0117] Barley: leaf spot disease (Pyrenophora graminea), net blotch disease (Pyrenophora teres), leaf blotch disease (Rhynchosporium secalis), loose smut disease (Ustilago tritici, U. nuda), and the like.

[0118] Rice: blast disease (Pyricularia oryzae), sheath blight disease (Rhizoctonia solani), bakanae disease (Gibberella fujikuroi), brown spot disease (Cochliobolus miyabeanus), damping-off disease (Pythium graminicola), bacterial leaf blight (Xanthomonas oryzae), bacterial seedling blight disease (Burkholderia plantarii), brown stripe disease (Acidovorax avenae), bacterial grain rot disease (Burkholderia glumae), Cercospora leaf spot disease (Cercospora oryzae), false smut disease (Ustilaginoidea virens), rice brown spot disease (Alternaria alternata, Curvularia intermedia), kernel discoloration of rice (Alternaria padwickii), pink coloring of rice grains (Epicoccum purpuras cens), and the like.

[0119] Tobacco: sclerotinia rot disease (Sclerotinia sclerotiorum), powdery mildew disease (Erysiphe cichor acearum), phytophthora rot disease (Phytophthora nicotianae), and the like.

[0120] Tulip: gray mold disease (Botrytis cinerea), and the like.

[0121] Sunflower: downy mildew disease (Plasmopara halstedii), sclerotinia rot disease (Sclerotinia sclerotiorum), and the like.

[0122] Bent grass: Sclerotinia snow blight (Sclerotinia borealis), Large patch (Rhizoctonia solani), Brown patch (Rhizoctonia solani), Dollar spot Sclerotinia homoeocarpa), blast disease (Pyricularia sp.), Pythium red blight disease (Pythium aphanidermatum), anthracnose disease (Colletotrichum graminicola), and the like.

[0123] Orchard grass: powdery mildew disease (Erysiphe graminis), and the like.

[0124] Soybean: purple stain disease (Cercospora kikuchii), downy mildew disease (Peronospora manshurica), phytophthora rot disease (Phytophthora sojae), rust disease (Phakopsora pachyrhizi), sclerotinia rot disease (Sclerotinia sclerotiorum , anthracnose disease (Colletotrichum truncatum), gray mold disease (Botrytis cinerea), Sphaceloma scab (Elsinoe glycines), melanoses (Diaporthe phaseolorum var. sojae), and the like.

[0125] Potato: hytophthora rot disease (Phytophthora infestans), early blight disease (Alternaria solani), scurf disease (Thanatephorus cucumeris), verticillium wilt disease (V erticillium albo-atrum, V. dahlia, V. nigrescens, and the like.

[0126] Banana: Panama disease (Fusarium oxysporuni), Sigatoka disease (Mycosphaerella fijiensis , M. musicola), and the like.

[0127] Rapeseed: sclerotinia rot disease (Sclerotinia sclerotiorum), root rot disease (Phorna lingam), black leaf spot disease (Alternaria brassicae), and the like.

[0128] Coffee: rust disease (Hemileia vaslatrix), anthracnose (Colletotrichum coffeanum), leaf spot disease (Cercospora coffeicola), and the like.

[0129] Sugarcane: brown rust disease (Puccinia melanocephala), and the like.

[0130] Com: zonate spot disease (Gloeocercospora sorghi), rust disease (Puccinia sorghi), southern rust disease (Puccinia polysora), smut disease (Ustilago maydis), brown spot disease (Cochliobolus heterostrophus), northern leaf blight (Setosphaeria turcica), and the like.

[0131] Cotton: seedling blight disease (Pythium sp.), rust disease (Phakopsora gossypii), sour rot disease (Mycosphaerella areola , anthracnose (Glomerella gossypii), and the like. IV. Pesticides

[0132] The presently disclosed compounds, including compounds according to (I), (la), (lb), (lai), (Ibl), (Ia2), (Ib2), (Ia3), (Ib3), (Ia4), (Ib4), (Ia5), (Ib5), (Ia6), (Ib6), (Ia7) and / or (Ib7), are useful for enhancing the effect of a variety of agrochemicals, including fungicides, antiviral agents, bactericides, herbicides, insecticidal / acaricidal agents, molluscicides, nematicides, soil pesticides, plant control agents, synergistic agents, fertilizers and soil conditioners.

[0133] In one embodiment, the presently disclosed compounds are useful for enhancing the fungicidal effect of a variety of fungicides. Fungicides for use with the presently disclosed compounds, such as a compound of Formulas (I), (la), (lb), (lai), (Ibl), (Ia2), (Ib2), (Ia3), (Ib3), (Ia4), (Ib4), (Ia5), (Ib5), (Ia6), (Ib6), (Ia7) and / or (Ib7), are well known to those of skill in the art and include, without limitation those set forth by class in Table 3:

[0134] Fungicides are cataloged more broadly by the Fungicide Resistance Action Committee (FRAC) in the FRAC Code List 2022 and reproduced in Appendix 1 and which is incorporated herein by reference in its entirety.

[0135] In one embodiment, a presently disclosed enhancer compound, such as a compound of Formulas Formulas (I), (la), (lb), (lai). (Ibl), (Ia2), (Ib2), (Ia3), (Ib3), (Ia4), (Ib4), (Ia5), (Ib5), (Ia6), (Ib6), (Ia7) and (Ib7), is used in combination with one or more compound from the Families or Groups set forth in Table 3, Appendix 1, or both. In certain embodiments, a presently disclosed enhancer is used in combination with one or more fungicides recited in column 1 of Table 3.

[0136] In particular embodiments, a disclosed enhancer is used in combination with one or more of a fungicide selected from the benzimidazoles, dicarboximides, phenylpyrroles, anilinopyrimidines, hydroxyanilides, carboxamides, phenyl amides, phosphonates, cinnamic acids, oxysterol binding protein inhibitors (OSBPI), triazole carboxamides, cymoxanil, carbamates, benzamides, demethylation inhibiting piperazines, demethylation inhibiting pyrimidines, demethylation inhibiting azoles, including imidazoles, and triazoles, such as cyproconazole, difenoconazole, fenbuconazole, flutriafol, mefentrifluconazole, metconazole, ipconazole, prothioconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, morpholines, cyflufenamid, metrafenone, pyriofenone, strobilurins, copper ammonium complex, copper hydroxide, copper oxide, copper oxychloride, copper sulfate, sulfur, lime sulfur, ethylenebisdithiocarbamates, aromatic hydrocarbons, phthalimides, guanidines, polyoxins, fluazinam and thiazolidines. Particular fungicides that are potentiated by use in combination with an enhancer according to the methods herein by administration of an apyrase inhibitor are coppers, such as copper octanoate, copper hydroxide and the like, myclobutanil, propiconazole, tebuconazole, epoxiconazole, difenoconazole, triticonazole, and prothioconazole.

[0137] In one embodiment, the combined treatment with a selected fungicide and an enhancer according to the present disclosure, such as a compound of Formulas (I), (la), (lb), (lai), (Ibl), (Ia2), (Ib2), (Ia3), (Ib3), (Ia4), (Ib4), (Ia5), (Ib5), (Ia6), (Ib6), (Ia7) and / or (Ib7), provides synergistic fungicidal activity against plant pathogenic fungi.

[0138] In one embodiment, the disclosure provides compositions and methods of treating plants or plant seeds infected with or at risk of being infected with a fungal pathogen. In one embodiment compositions of the present disclosure comprise a formulation of a fungicide, an enhancer and a phytologically acceptable carrier. In another embodiment, the fungicide and enhancer are administered in separate compositions. In further embodiments, an agricultural or horticultural fungicide is used in combination with other compounds in addition to the presently disclosed apyrase inhibitors. As with the apyrase inhibitors, such other compounds can be administered in the same or separate compositions as the fungicide. Examples of the other components include known carriers to be used to conduct formulation. Additional examples thereof include conventionally-known herbicides, insecticidal / acaricidal agents, nematodes, soil pesticides, plant control agents, synergistic agents, fertilizers, soil conditioners, and animal feeds. In one embodiment, the inclusion of such other components yields synergistic effects on crop growth.

[0139] In one embodiment, the presently disclosed compounds, including compounds according to Formulas (I), (la), (lb), (lai), (Ibl), (Ia2), (Ib2), (Ia3), (Ib3), (Ia4), (Ib4), (Ia5), (Ib5), (Ia6), (Ib6), (Ia7) and / or (Ib7), are used to potentiate the effect of a herbicide. Exemplary herbicides for use in combination with the present compounds are known to those of skill in the art and include, without limitation, those described in Appendix 2. By way of example, suitable herbicides for use in combination with the present compounds include inhibitors of acetyl CoA synthase, inhibitors of acetolactate synthesis, inhibitors of microtubule assembly, inhibitors of microtubule organization, auxin mimics, photosynthesis inhibitors, deoxy-D-xylulose phosphate synthase inhibitors, enolpyruvyl shikimate phosphate synthase inhibitors, phytoene desaturase inhibitors, glutamine synthetase inhibitors, dihydropteroate synthesis inhibitors, protoporphyrinogen oxidase inhibitors, cellulose synthesis inhibitors, uncouplers, hydroxyphenyl pyruvate dioxygenase inhibitors, fatty acid thioesterase inhibitors, serine-threonine protein phosphatase inhibitors, solanesyl diphosphate synthase inhibitors, inhibitors of very long-chain fatty acid synthesis, homogentisate solanesyltransferase inhibitors, lycopene cyclase inhibitors, In one embodiment, the presently disclosed compounds, including compounds according to Formulas (I). (la), (lb), (lai), (Ibl), (Ia2), (Ib2), (Ia3). (Ib3), (Ia4), (Ib4), (Ia5), (Ib5), (Ia6), (Ib6), (Ia7) and (Ib7), are used to potentiate the effect of an insecticide. Exemplary insecticides for use in combination with the present compounds are known to those of skill in the art and include, without limitation, those described in Appendix 3.

[0140] V. Formulations

[0141] The present disclosure provides specific apyrase inhibitors, such as compounds of Formulas (I), (la). (Ib), (lai), (Ibl), (Ia2), (Ib2), (Ia3), (Ib3), (Ia4), (Ib4), (Ia5), (Ib5), (Ia6), (Ib6), (Ia7) and (Ib7), to enhance the potency of pesticides to effectively restrict the growth of plant pathogenic species. In certain non-limiting embodiments, the apyrase inhibitors can be provided at: from about 0.01 to about 80% weight to weight in a final composition, or from about 25% to about 55%, such as from about 30% to about 50%, from about 35% to about 45%, such as about 0.01, 0.05, 0.1, 0.5, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.5, 3.0, 4.0, 5.0, 7.5, 10, 20, 30, 40, 50, 55, 60 or 80% weight to weight in a final composition. In one embodiment the apyrase inhibitors are provided in liquid form at from about 0.01 to about 50%, such as from about 15% to about 50%, from about 20% to about 45%, from about 25% to about 40%, such as about 0.01, 0.05, 0.1, 0.5, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.5, 3.0, 4.0, 5.0, 7.5, 10, 15, 20, 30, 40 or 50% volume to volume in a final diluted composition. The skilled artisan will recognize that the formulation of the pesticide, the apyrase inhibitor or a combination thereof can be provided in a concentrate that can be diluted prior to use, or can be provided in a diluted form ready for treatment.

[0142] The enhancer, pesticide and combinations thereof are not particularly limited by the dosage form. Examples of the dosage form include wettable powders, emulsions, emulsifiable concentrates, oil- dispersible liquids, powders, granules, water-soluble agents, suspensions, granular wettable powders, and tablets. The method for preparing formulation is not particularly limited, and conventionally-known methods may be adopted depending on the dosage form.

[0143] Several formulation examples are described below. The preparation formulations shown below are merely examples, and may be modified within a range not contrary to the essence of the present disclosure. For example, additional active and inert components may be added to the formulations below.

[0144] "Part" means "part by mass" unless otherwise specified.

[0145] Formulation Example 1: Wettable Powders 40 parts of an enhancer disclosed herein, 53 parts of diatomaceous earth, 4 parts of ethoxylated higher alcohol sulfate ester combined with a suitable solid carrier such as magnesium sulfate, and 3 parts of alkyl naphthalene sulfonate are mixed uniformly, and then finely pulverized to obtain wettable powders containing 40 parts by mass of the enhancer.

[0146] Formulation Example 2: Emulsifiable Concentrates

[0147] 3 parts of an enhancer disclosed herein, 60 parts of mixed petroleum distillates, 27 parts of dimethyl lactamide, and 10 parts of tri styrylphenol ethoxylates are mixed and dissolved to obtain an emulsifiable concentrate containing 3% by mass of the enhancer.

[0148] Formulation Example 3: Granules

[0149] 5 parts of an enhancer disclosed herein, 10 parts of talc, 38 parts of clay, 10 parts of bentonite, 30 parts of sodium lignosulfonate and 7 parts of sodium alkyl sulfate are mixed uniformly, and then finely pulverized, followed by conducting fluidized bed granulation to make the median particle diameter thereof be 0.2 to 2.0 mm, and thus granules containing 5% by mass of an enhancer on a dry weight basis disclosed herein are obtained.

[0150] Formulation Example 4: Granules

[0151] 5 parts of an enhancer disclosed herein, 73 parts of clay, 20 parts of bentonite, 1 part of sodium dioctyl sulfosuccinate, and 1 part of potassium phosphate are mixed and then pulverized, followed by adding water thereto, and then kneading the mixture. Then, extrusion granulation is conducted, and the resultant is dried to obtain granules containing 5% by mass of the enhancer on a dry weight basis.

[0152] Formulation Example 5: Suspensions

[0153] 10 parts of an enhancer disclosed herein, 4 parts of polyoxyethylene alkyl ether, 2 parts of 3 kDa sodium polycarboxylate as dispersant, 10 parts of glycerin, 0.2 parts of xanthan gum, 0.1 parts of biocides as stabilizer, 0.1 parts of organosilicone antifoam emulsion and 73.6 parts of water are mixed, and then wet pulverized until the particle size is 3 microns or less to obtain a suspension containing 10% by mass of the enhancer. Formulation Example 6: Oil Dispersible Concentrates

[0154] 40 parts of an enhancer disclosed herein, 5 parts of Atlox 4914, 5 parts of organo-modified bentonite and 50 parts of methylated rapeseed oil as carrier are mixed uniformly and then wet pulverized until the median particle size is 3 microns or less to obtain an oil dispersible concentrate containing 40% by mass of the enhancer.

[0155] The skilled artisan will recognize that the various compositions are used commercially at varying concentrations and formulations. For example, it is common for fungicides to be formulated as liquids commercially at 10 - 40% concentrations. In one embodiment, the presently disclosed enhancers allow the use of a lower amount of a given fungicide due to the enhanced efficacy of fungicide in combination with an enhancer disclosed herein.

[0156] VI. Methods for Assessing Enhancer Activity

[0157] Apyrase inhibitors useful as enhancers of pesticidal activity are assessed using an in vitro assay. The method of Windsor, Bio Techniques 33 1024-1030 (November 2002) was used as follows

[0158] Screen for Apyrase Inhibitors -

[0159] 96 well plates were used for the assay: (Greiner bio-one: REF- 655901- 96 well, PS, F-bottom, Clear, Non-binding)

[0160] Buffers:

[0161] Reaction Buffer: 60mM Hepes; 3mM MgCh, 3mM CaCT and 3mM ATP (pH 6.5) Development Buffer A: 2% aqueous ammonium molybdate

[0162] Development Buffer B: 11% ascorbic acid in 37.5% TCA in water

[0163] Stop buffer C: 2% trisodium citrate in 2% acetic acid solution in water

[0164] • Add 100 pl of reaction buffer to each well.

[0165] • Add lOpl of DMSO (control) or inhibitor / compound or compounds such as N1915 or orthovanadate to each well, (use inhibitor cone at ImM; orthovanadate at 2mM and N1915 at ImM) • Add 10|il of apyrase (concentration based on optimization - Dilute lU / pl enzyme to different concentrations such as 0.1U, 0.05U, 0.0025, 0.001 U, 0.0005U- to find a good range)

[0166] • Incubate plate at room temperature for Ihr

[0167] • Mix development buffer A and B in the ratio of 1 : 1.5 (just before use).

[0168] • Add 50ul of A:B mix in each well (incubate for 2 mins)

[0169] • Add 50ul of C in each well

[0170] • Measure / Read Absorbance of plate @ 630nm

[0171] Inhibitory data for the apyrase assay described above are provided for selected compounds in Table 4.

[0172] In Table 4, D indicates inhibition of < 10%, C indicates inhibition of from 10% to 20%, B indicates inhibition of from 20% to 30%, and A indicates inhibition above 30%:

[0173]

[0174] With reference to Table 4, percent inhibition of apyrase is reported as the rounded average of at least two assay results.

[0175] Method 2: In vitro Assessment of combination activity

[0176] Selected compounds are assessed in combination with fungicides against a range of commercially important plant pathogenic fungi.

[0177] The test is conducted as follows. A fungicide is applied to a fungal plant pathogen at a rate slightly below that at which gives any control, in combination with a suitable dose of the test compound. The test compound is recorded as active if control of the pathogen is observed.

[0178] In more detail, the test is conducted as follows. For each combination of fungicide, pathogen and test compound, the following wells are used. Well 1 contains a fungal pathogen growing on agar, and a fungicide at a rate just below that at which it gave any control of the pathogen. Well 2 is the same as Well 1, except that the test compound is also added at Rate 1 . Well 3 is the same as Well 2, except that the test compound is added at Rate 2, where Rate 2 is higher than Rate 1. Finally, as a benchmark, Well 4 is the same as Well 1, except that it contains the fungicide at a higher rate, at which it gives partial control of the pathogen. Each of the Wells 1 to 4 are run in duplicate, giving a total of 8 wells for each combination of fungicide, pathogen and test compound. For each well, after a suitable period of incubation, a visual assessment of the % control of the pathogen by the fungicide is made. Test compounds are scored as inactive, active or highly active.

[0179] The following fungicides are used in this assay: azoxystrobin, fluxapyroxad, and desthio prothioconazole. The following fungal pathogens are used in this assay: First, a strain of Zymoseptoria tritici with a reduced susceptibility to strobilurin fungicides; second a strain of Zymoseptoria tritici with a reduced susceptibility to SDHI fungicides (i.e., those that inhibit succinate dehydrogenase); and third, Microdochium nivale. In this assay, exemplary compounds show significant activity in the combination assay and superior to that of the fungicide alone.

[0180] Method 3: Greenhouse Crop Tests

[0181] In this method, exemplary compounds were evaluated for their ability to control Brown Rust (Puccinia reconditd) on wheat, in a controlled greenhouse environment in combination with one of four fungicides, Amistar, Imtrex, Proline or Balaya. In these studies, JB Diego wheat plants were used. Seeds were sown in 9cm diameter pots to a depth of 1 to 2 cm using Petersfield potting compost (75% medium grade peat, 12% screened sterilized loam, 3% medium grade vermiculite, 10% grit (5mm screened, lime free), 1.5 kg PG mix per m3, lime to pH5.5-6.0 and wetting agent (Vitax Ultrawet 200 ml per m3) and germinated / grown at 23C under a 16 h day / 8 h night light regime. Plants were treated two to three weeks after sowing when they were at the BBCH 11 growth stage (first pair of true leaves (unifoliate) unfolded. A track sprayer was used to treat the plants with the mixture of commercial fungicide and test compound using a water volume of 200 L / ha; enhancer test compound was included at 20 ppm. Plants were inoculated with the Puccinia triticina (Brown rust on wheat plants) 24 hours after treatment. Four replicates were used for each combination of fungicide and test compound. Each plant was evaluated at fourteen days (once the disease symptoms were fully expressed) for % control of the disease. Appropriate controls were used for all experiments, including an ‘inoculation check’ wherein plants were inoculated with their specific pathogen to assess disease levels. Also, each commercial fungicide was tested on its own as a part of each treatment, this being benchmark against which the experimental compounds were evaluated. Exemplary compounds demonstrated enhanced disease control in combination with fungicides as compared to disease control observed with fungicide alone. That is, the present compounds, although not fungicidal by themselves, enhance the activity of fungicides, thus the enhancer compounds work synergistically in combination with fungicides to control disease.

[0182] In these studies the fungicide was applied at the following rates:

[0183] In this method, working examples enhanced the activity of Amistar against Brown Rust on wheat by significant amounts relative to the activity of Amistar alone. Compounds 1-1, 1-5, 1-6 and 1-7 all provided greater than 50% additional disease control benefit in combination with Amistar over Amistar alone. In contrast, Windsor compound XVI only provided 17. 1 % enhancement of Brown Rust control relative to Amistar alone. The superior activity of the presently disclosed compounds in potentiating the effect of fungicides in the greenhouse study is significant and unexpected in view of the in vitro apyrase inhibitory data for these compounds. For example, Windsor compound XVI exhibited superior apyrase inhibitory activity in vitro than present compound 1-5, but was far less active than this compound in enhancing the activity of fungicides, including Amistar, against Brown Rust on wheat.

[0184] Working examples also enhanced the activity of Imtrex against Brown Rust on wheat by significant amounts relative to Imtrex treatment alone. For example, compound 1-1 provided greater than 50% additional disease control benefit in combination with Imtrex over Imtrex alone. Compounds 1-5 and 1-6 provided greater than 30% additional Brown Rust control relative to Imtrex alone, and compound 1-7 provided greater than 20% additional Brown Rust control in combination with Imtrex over Imtrex alone. In contrast, Windsor compound XVI only provided 4.3% enhancement of Brown Rust control relative to Imtrex alone.

[0185] Working example 1-1 enhanced the activity of Balaya against Brown Rust on wheat by over 50% over Balaya alone. Working examples 1-5, and 1-7 provided greater than 30% additional Brown Rust control benefit in combination with Balaya over Balaya alone. In contrast, Windsor compound XVI provided 27.6% enhancement additional Brown Rust control in combination with Balaya over Balaya alone.

[0186] Method 4: Enhancement of herbicide activity

[0187] This method demonstrates the enhancement of herbicidal activity provided by the present compounds. Specifically, Amaranthus retroflexus (pigweed) was treated pre-emergence with metribuzin alone or in combination with an enhancer compound disclosed herein. Fifteen seeds of Amaranthus retroflexus were sown in soil in each pot and then sprayed with a mixture of metribuzin at the appropriate rate shown in Table 5 and the compound of this invention at 100 g / ha using a track sprayer at a water volume of 200 L / hectare. Small amounts of acetone were used to aid solubility. The pots were watered immediately after sowing and treatment and then allowed to stand in a glasshouse. Assessment of kill was made seven and fourteen days after treatment. The test included four replicates for each treatment and the control. Results are shown in Table 5. Exemplary compounds demonstrated significant enhancement of metribuzin herbicidal activity at seven and fourteen days.

[0188] Table 5. Pre-Emergence Amaranthus Kill Percentage

[0189] VII. Methods for Making Enhancer Compounds

[0190] Exemplary enhancer compounds were purchased from commercial suppliers, such as Enamine, located at Industriepark Hoechst, G837. 65926 Frankfurt am Main Germany.

[0191] Compounds disclosed herein, including compounds of Formulas (I), (la), (lb), (lai), (Ibl), (Ia2), (Ib2), (Ia3), (Ib3), (Ia4), (Ib4), (Ia5), (Ib5), (Ia6), (Ib6), (Ia7) and (Ib7), can be prepared as will be understood by those of skill upon consideration of the present disclosure.

[0192] Analytical methods

[0193] LCMS methodology

[0194] Electrospray mass spectroscopy (MS) was carried out using the following method;

[0195] LCMS (Agilent- Acid):

[0196] LC model: Agilent 1260 (Pump type: Binary Pump, Detector type: DAD) MS model: Agilent G6125B Quadrupole. Column: Nanochrom x ChromCore C18 3pm 4.6*50mm. Column temperature: 40 °C. Acquisition of wavelength: 214 nm, 254 nm. Mobile phase: A: 0.04% TFA aqueous solution, B: ACN (0.02% TFA). Run time: 3 min. MS: Ion source: ES+. MS range: 100-1400 m / z. Fragmentor: 70. Drying gas flow: 12 L / min. Nebulizer pressure: 35 psi. Drying gas temperature: 350 °C. Vcap: 3.5 kV.

[0197] UPLC (Waters- Acid): Instrument type: Waters Acquity UPLC. Pump type: Binary Pump. Detector type: PDA. LC conditions: Column: YMC-Triart C18 ExRS, 3 pm 2.1*100mm. Acquisition wavelength: 214 nm, 254 nm. Mobile Phase: A: 0.02% TFA aqueous solution, B: ACN (0.02% TFA).

[0198] Instrument type: Waters Acquity UPLC. Pump type: Binary Pump. Detector type: PDA. LC conditions: Column: YMC-Triart C18 ExRS, 3 pm 2.1 *100mm. Acquisition wavelength: 214 nm, 254 nm. Mobile Phase: A: lOmmol NH4HCO3 aqueous solution, B:ACN.

[0199] NMR

[0200] Nuclear magnetic resonance spectra were recorded on a Broker Avance III 400MHz instrument at 400 MHz for 1H nuclei as specified. Samples were recorded in deuterated solvent as specified, and data acquired at 25 °C. Chemical shifts are reported in ppm on the 8 scale and referenced to the appropriate solvent peak. In reporting spectral data, the following abbreviations have been used: s, singlet; br s, broad singlet; d, doublet; t, triplet; q, quartet; m, multiplet.

[0201] Synthesis of enhancer compounds

[0202] Scheme 1 illustrates a suitable preparation for compounds of Formula (I) disclosed herein.

[0203] Scheme 1

[0204] With reference to Scheme 1, generally, the substituted thiophene starting material (commercially available), is reacted with an activated carboxyl group in the presence of a hindered amine base, such as triethylamine, pyridine and / or 4-dimethylaminopyridine. Additional methods for synthesizing amide compounds of Formula (I) are known to those of skill in the art and for example in Bioorganic & Medicinal Chemistry Letters 2023, 79, 129069 (reaction with acid chloride), and European Journal of Medicinal Chemistry 2016, 122, 619-634 (reaction with acids).

[0205] Scheme 2 illustrates a suitable preparation for other compounds of Formula (I). With reference to Scheme 2, the chloride starting material is reacted with an excess of amine, or with the amine in the presence of a hindered amine base, such as triethylamine and / or pyridine. Additional methods for synthesizing ester compounds of Formula (I) are known to those of skill in the art and for example in Molecules 2020, 25, 2523 Angewandte Chemie, International Edition 2015, 54, 2849-2853; European Journal of Medicinal Chemistry 1980, 15, 413-418.

[0206] General Procedure A

[0207] A4 11-1

[0208] Step 1: ethyl 2-(2-(4-fluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate

[0209] To a solution of 4- fluorophenoxyacetic acid (150 mg, 0.88 mmol, 2.0 eq) in DMF (2 mL) was added ethyl 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate (100 mg, 0.44 mmol, 1.0 eq), DIEA (172 mg, 1.33 mmol, 3.0 eq) and IIATU (202 mg, 1.2 mmol, 2.7 eq). The reaction mixture was stirred at room temperature for 2 hours, and then it was poured into water (10 mL). The resulting solid was collected by filtration and washed with water (5 mL x 3), then dried under vacuum to give the desired product as a white solid (13 mg, 7.7% yield).

[0210] Note - DIEA = N,N-Di-isopropylethylamine; HATU = Hexafluorophosphate Azabenzotriazole Tetramethyl Uronium

[0211] LCMS (Agilent- Acid): Rt: 2.48 min; m / z [M+Na]+= 400.1

[0212] UPLC (Waters-Acid): Rt: 5.65 min, 98.6% purity

[0213] XII NMR (400 MHz, DMSO) 5 11.82 (s, III), 7.20 (dd, . / = 12.0, 5.6 IIz, 211), 7.14 - 7.04 (m, 211), 4.85 (s, 2H), 4.30 (q, J = 7.2 Hz, 2H), 2.72 (s, 2H), 2.62 (s, 2H), 1.73 (s, 4H), 1.30 (t, J = 7.2 Hz, 3H).

[0214] Table 5: The following compounds were synthesized via the General Procedure A

[0215] Step 1: ethyl 2-(2-(pyridin-2-yloxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate

[0216] To a solution of 2-(pyridin-2-yloxy)acetic acid (136 mg, 0.88 mmol, 2.0 eq) in DCM (4 mL), pyridine (246 mg, 3.11 mmol, 7.0 eq) and ethyl 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate (100 mg, 0.44 mmol, 1.0 eq) were added at 0°C. After stirring for 10 minutes at this temperature, POC13 (408 mg, 2.66 mmol, 6.0 eq) was introduced. The mixture was then stirred at room temperature for 16 hours. Water (10 mL) was added, and the mixture was extracted with dichloromethane (3 x 10 mL). The organic layer was dried over Na2SO4, filtered, and concentrated. The crude residue was purified by reversed- phase column chromatography (ACN:H2O = 8:2) to yield the product as a white solid (84 mg, 50% yield).

[0217] LCMS (Agilent-Acid): Rt: 2.13 min; m / z [M+H]+=361.1

[0218] UPLC (Waters-Acid): Rt: 4.14 min, 97.00% purity

[0219] II NMR (400 MHz, DMSO): 5 11.16 (s, 1H), 7.72 (dd, 7 = 6.8, 1.6 Hz, 1H), 7.50 (ddd, 7 = 8.8, 6.8, 2.0 Hz, 1H), 6.43 (d, 7 = 9.2 Hz, 1H), 6.36 - 6.24 (m, 1H), 4.89 (s, 2H), 4.27 (q, J = 7.2 Hz, 2H). 2.70 (s, 2H), 2.59 (s, 2H), 1.72 (s, 4H), 1.30 (t, 7 = 7.2 Hz, 3H). Table 6: The following compounds were synthesized via the General Procedure B

[0220] General Procedure C

[0221] Step 1: ethyl 2-(2-(pyrimidin-2-yloxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3- carboxylate

[0222] To a solution of 2-(pyrimidin-2-yloxy)acetic acid (50 mg, 0.35 mmol, 1.0 eq) in acetonitrile (2 mL) were added TCFH (136 mg, 0.48 mmol, 1.5 eq) and NMI (80 mg, 0.97 mmol, 3.0 eq). The reaction mixture was stirred at room temperature for 30 minutes. Then, ethyl 2-amino-4, 5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate (146 mg, 1.1 eq) was added, and the mixture was stirred at room temperature for another 30 minutes. The mixture was poured into water (10 mL), and the resulting solid was collected by filtration. The filter cake was washed with water (3 x 5 mL) and dried under vacuum to yield the desired product as a white solid (47 mg, 30% yield).

[0223] Note - TCFH = N,N,N',N'-Tetramethylchloroformamidinium Hexafluorophosphate and NMI = N- Methylimidazole.

[0224] LCMS (Agilent- Acid): Rt: 2.28 min; m / z [M+H]+=362. 1 UPLC (Waters-Acid): Rt: 4.82 min, 99.46% purity H NMR (400 MHz, DMSO): 5 11.51 (s, 1H), 8.68 (d, J = 4.8 Hz, 2H), 7.25 (t, J = 4.8 Hz, 1H). 5.10 (s, 2H), 4.27 (d, J = 7.2 Hz, 2H), 2.70 (s, 2H), 2.61 (s, 2H), 1.79 - 1.65 (m, 4H). 1.29 (t. J = 7.2 Hz. 3H).

[0225] General Procedure D

[0226] Step 1: ethyl 2-(2-((4-fluorophenyl)sulfonyI)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3- carboxylate

[0227] To a solution of ethyl 2-(2-((4-fluorophenyl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3- carboxylate (50 mg,0.12 mmol, l.Oeq) in DCM (2 mL) was added m-CPBA (88 mg, 0.50 mmol, 4.0eq, 85% purity). The reaction mixture was stirred at room temperature for 16 h. The reaction mixture was added 10 % Na2CO3 (5 mL), extracted with DCM (3*5 mL) dried over Na2SO4, filtered and concentrated. The crude residue was purified by reversed-phase column (ACN:H2O=6 / 4) to give the product (16 mg, 30% yield) as a white solid.

[0228] LCMS (Agilent- Acid): Rt : 2.30 min; m / z [M+Na]+=448.0

[0229] UPLC (Waters- Acid): Rt : 4.98 min, 96.50% purity

[0230] H NMR (400 MHz, DMSO): 5 11.51 (s, 1H), 8.68 (d, J = 4.8 Hz, 2H), 7.25 (t, J = 4.8 Hz, 1H), 5.10 (s, 2H), 4.27 (d, J = 7.2 Hz, 2H), 2.70 (s, 2H), 2.61 (s, 2H), 1.79 - 1.65 (m, 4H), 1.29 (t, J = 7.2 Hz, 3H).

[0231] Table 7: The following compounds were synthesized via the General Procedure D

[0232] APPENDIX 1

[0233]

[0234]

[0235]

[0236]

[0237]

[0238]

[0239]

[0240]

[0241] APPENDIX 2

[0242] MODE OF ACTION CHEMICAL CLASSIFICATION ACTIVE

[0243] Inhibition of Acetyl CoA

[0244] Carboxylase Cyclohexanediones (DIMs) Alloxydim

[0245] Inhibition of Acetyl CoA

[0246] Carboxylase Cyclohexanediones (DIMs) Butroxydim

[0247] Inhibition of Acetyl CoA

[0248] Carboxylase Cyclohexanediones (DIMs) Clethodim

[0249] Inhibition of Acetyl CoA

[0250] Carboxylase Cyclohexanediones (DIMs) Cloproxydim

[0251] Inhibition of Acetyl CoA

[0252] Carboxylase Cyclohexanediones (DIMs) Cycloxydim

[0253] Inhibition of Acetyl CoA

[0254] Carboxylase Cyclohexanediones (DIMs) Prof oxydim

[0255] Inhibition of Acetyl CoA

[0256] Carboxylase Cyclohexanediones (DIMs) Sethoxydim

[0257] Inhibition of Acetyl CoA

[0258] Carboxylase Cyclohexanediones (DIMs) Tepraloxydim

[0259] Inhibition of Acetyl CoA

[0260] Carboxylase Cyclohexanediones (DIMs) Tralkoxydim

[0261] Inhibition of Acetyl CoA Aryloxyphenoxy-propionates

[0262] Carboxylase (FOPs) Clodinafop-propargyl

[0263] Inhibition of Acetyl CoA Aryloxyphenoxy-propionates

[0264] Carboxylase (FOPs) Clofop

[0265] Inhibition of Acetyl CoA Aryloxyphenoxy-propionates

[0266] Carboxylase (FOPs) Cyhalofop-butyl

[0267] Inhibition of Acetyl CoA Aryloxyphenoxy-propionates

[0268] Carboxylase (FOPs) Diclofop-methyl

[0269] Inhibition of Acetyl CoA Aryloxyphenoxy-propionates

[0270] Carboxylase (FOPs) Fenoxaprop-ethyl

[0271] Inhibition of Acetyl CoA Aryloxyphenoxy-propionates

[0272] Carboxylase (FOPs) Fenthiaprop

[0273] Inhibition of Acetyl CoA Aryloxyphenoxy-propionates

[0274] Carboxylase (FOPs) Fluazifop-butyl

[0275] Inhibition of Acetyl CoA Aryloxyphenoxy-propionates

[0276] Carboxylase (FOPs) Haloxyfop-methyl

[0277] Inhibition of Acetyl CoA Aryloxyphenoxy-propionates

[0278] Carboxylase (FOPs) Isoxapyrifop

[0279] Inhibition of Acetyl CoA Aryloxyphenoxy-propionates

[0280] Carboxylase (FOPs) Metamifop

[0281] Inhibition of Acetyl CoA Aryloxyphenoxy-propionates

[0282] Carboxylase (FOPs) Quizalofop-ethyl

[0283] Inhibition of Acetyl CoA Carboxylase Phenylpyrazoline Pinoxaden Inhibition of Acetolactate

[0284] Synthase Pyrimidinyl benzoates Bispyribac-sodium

[0285] Inhibition of Acetolactate Pyribenzoxim (prodrug of

[0286] Synthase Pyrimidinyl benzoates bispyribac)

[0287] Inhibition of Acetolactate

[0288] Synthase Pyrimidinyl benzoates Pyriftalid

[0289] Inhibition of Acetolactate

[0290] Synthase Pyrimidinyl benzoates Pyriminobac-methyl

[0291] Inhibition of Acetolactate

[0292] Synthase Pyrimidinyl benzoates Pyrithiobac-sodium

[0293] Inhibition of Acetolactate

[0294] Synthase Sulfonanilides Pyrimisulfan

[0295] Inhibition of Acetolactate

[0296] Synthase Sulfonanilides Triafamone

[0297] Inhibition of Acetolactate

[0298] Synthase Triazolopyrimidine - Type 1 Cloransulam-methyl

[0299] Inhibition of Acetolactate

[0300] Synthase Triazolopyrimidine - Type 1 Diclosulam

[0301] Inhibition of Acetolactate

[0302] Synthase Triazolopyrimidine - Type 1 Florasulam

[0303] Inhibition of Acetolactate

[0304] Synthase Triazolopyrimidine - Type 1 Flumetsulam

[0305] Inhibition of Acetolactate

[0306] Synthase Triazolopyrimidine - Type 1 Metosulam

[0307] Inhibition of Acetolactate

[0308] Synthase Triazolopyrimidine - Type 2 Penoxsulam

[0309] Inhibition of Acetolactate

[0310] Synthase Triazolopyrimidine - Type 2 Pyroxsulam

[0311] Inhibition of Acetolactate

[0312] Synthase Sulfonylureas Amidosulfuron

[0313] Inhibition of Acetolactate

[0314] Synthase Sulfonylureas Azimsulfuron

[0315] Inhibition of Acetolactate

[0316] Synthase Sulfonylureas Bensulfuron-methyl

[0317] Inhibition of Acetolactate

[0318] Synthase Sulfonylureas Chlorimuron-ethyl

[0319] Inhibition of Acetolactate

[0320] Synthase Sulfonylureas Chlorsulfuron

[0321] Inhibition of Acetolactate

[0322] Synthase Sulfonylureas Cinosulfuron

[0323] Inhibition of Acetolactate

[0324] Synthase Sulfonylureas Cyclosulfamuron

[0325] Inhibition of Acetolactate

[0326] Synthase Sulfonylureas Ethametsulfuron-methyl

[0327] Inhibition of Acetolactate

[0328] Synthase Sulfonylureas Ethoxysulfuron

[0329] Inhibition of Acetolactate

[0330] Synthase Sulfonylureas Flazasulfuron

[0331] Inhibition of Acetolactate Sulfonylureas Flucetosulfuron Synthase

[0332] Inhibition of Acetolactate

[0333] Synthase Sulfonylureas Flupyrsulfuron-methyl-Na

[0334] Inhibition of Acetolactate

[0335] Synthase Sulfonylureas Foramsulfuron

[0336] Inhibition of Acetolactate

[0337] Synthase Sulfonylureas Halosulfuron-methyl

[0338] Inhibition of Acetolactate

[0339] Synthase Sulfonylureas Imazosulfuron

[0340] Inhibition of Acetolactate

[0341] Synthase Sulfonylureas lodosulfuron-methyl-Na

[0342] Inhibition of Acetolactate

[0343] Synthase Sulfonylureas Mesosulfuron-methyl

[0344] Inhibition of Acetolactate

[0345] Synthase Sulfonylureas Metazosulfuron

[0346] Inhibition of Acetolactate

[0347] Synthase Sulfonylureas Metsulfuron-methyl

[0348] Inhibition of Acetolactate

[0349] Synthase Sulfonylureas Nicosulfuron

[0350] Inhibition of Acetolactate

[0351] Synthase Sulfonylureas Orthosulfamuron

[0352] Inhibition of Acetolactate

[0353] Synthase Sulfonylureas Oxasulfuron

[0354] Inhibition of Acetolactate

[0355] Synthase Sulfonylureas Primisulfuron-methyl

[0356] Inhibition of Acetolactate

[0357] Synthase Sulfonylureas Propyrisulfuron

[0358] Inhibition of Acetolactate

[0359] Synthase Sulfonylureas Prosulfuron

[0360] Inhibition of Acetolactate

[0361] Synthase Sulfonylureas Pyrazosulfuron-ethyl

[0362] Inhibition of Acetolactate

[0363] Synthase Sulfonylureas Rimsulfuron

[0364] Inhibition of Acetolactate

[0365] Synthase Sulfonylureas Sulfometuron-methyl

[0366] Inhibition of Acetolactate

[0367] Synthase Sulfonylureas Sulfosulfuron

[0368] Inhibition of Acetolactate

[0369] Synthase Sulfonylureas Triasulfuron

[0370] Inhibition of Acetolactate

[0371] Synthase Sulfonylureas Tribenuron-methyl

[0372] Inhibition of Acetolactate

[0373] Synthase Sulfonylureas Thifensulfuron-methyl

[0374] Inhibition of Acetolactate

[0375] Synthase Sulfonylureas Trifloxysulfuron-Na

[0376] Inhibition of Acetolactate

[0377] Synthase Sulfonylureas Triflusulfuron-methyl

[0378] Inhibition of Acetolactate

[0379] Synthase Sulfonylureas Tritosulfuron

[0380] Inhibition of Acetolactate

[0381] Synthase Imidazolinones Imazamethabenz-methyl

[0382] Inhibition of Acetolactate

[0383] Synthase Imidazolinones Imazamox Inhibition of Acetolactate Synthase Imidazolinones Imazapic

[0384] Inhibition of Acetolactate Synthase Imidazolinones Imazapyr

[0385] Inhibition of Acetolactate Synthase Imidazolinones Imazaquin

[0386] Inhibition of Acetolactate Synthase Imidazolinones Imazethapyr

[0387] Inhibition of Acetolactate Synthase Triazolinones Flucarbazone-Na

[0388] Inhibition of Acetolactate Synthase Triazolinones Propoxycarbazone-Na

[0389] Inhibition of Acetolactate Synthase Triazolinones Thiencarbazone-methyl

[0390] Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazines Atraton Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazines Atrazine Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazines Ametryne Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazines Aziprotryne=aziprotryn Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazines Chlorazine Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazines CP 17029 Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazines Cyanazine Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazines Cyprazine Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazines Desmetryne Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazines Dimethametryn Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazines Dipropetryn Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazines Eglinazine-ethyl Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazines Ipazine Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazines Methoprotryne=methoprotryn Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazines procyazine Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazines Proglinazine-ethyl Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazines Prometon Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazines Prometryne Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazines Propazine Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazines Sebuthylazine Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazines Secbumeton Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazines Simetryne Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazines Simazine Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazines Terbumeton Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazines Terbuthylazine Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazines Terbutryne Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazines Trietazine

[0391] Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazolinone Amicarbazone

[0392] Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazinones Ethiozin Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazinones Hexazinone Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazinones Isomethiozin Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazinones Metamitron Inhbition of Photosynthesis at PSII - Serine 264 Binders Triazinones Metribuzin

[0393] Inhbition of Photosynthesis at PSII - Serine 264 Binders Uracils Bromacil Inhbition of Photosynthesis at PSII - Serine 264 Binders Uracils Isocil Inhbition of Photosynthesis at PSII - Serine 264 Binders Uracils Lenacil Inhbition of Photosynthesis at PSII - Serine 264 Binders Uracils Terbacil

[0394] Inhbition of Photosynthesis at PSII - Serine 264 Binders Phenlcarbamates Chlorprocarb Inhbition of Photosynthesis at PSII - Serine 264 Binders Phenlcarbamates Desmedipham Inhbition of Photosynthesis at PSII - Serine 264 Binders Phenlcarbamates Phenisopham Inhbition of Photosynthesis at PSII - Serine 264 Binders Phenlcarbamates Phenmedipham

[0395] Inhbition of Photosynthesis at PSII - Serine 264 Binders Pyridazinone Chloridazon (=pyrazon) Inhbition of Photosynthesis at PSII - Serine 264 Binders Pyridazinone Brompyrazon Inhbition of Photosynthesis at PSII - Serine 264 Binders Ureas Benzthiazuron Inhbition of Photosynthesis at Ureas PSII - Serine 264 Binders Bromuron Inhbition of Photosynthesis at PSII - Serine 264 Binders Ureas Buturon Inhbition of Photosynthesis at Ureas PSII - Serine 264 Binders Chlorbromuron Inhbition of Photosynthesis at PSII - Serine 264 Binders Ureas Chlorotoluron Inhbition of Photosynthesis at PSII - Serine 264 Binders Ureas Chloroxuron Inhbition of Photosynthesis at PSII - Serine 264 Binders Ureas Difenoxuron Inhbition of Photosynthesis at PSII - Serine 264 Binders Ureas Dimefuron Inhbition of Photosynthesis at PSII - Serine 264 Binders Ureas Diuron Inhbition of Photosynthesis at PSII - Serine 264 Binders Ureas Ethidimuron Inhbition of Photosynthesis at PSII - Serine 264 Binders Ureas Fenuron Inhbition of Photosynthesis at PSII - Serine 264 Binders Ureas Fluometuron Inhbition of Photosynthesis at PSII - Serine 264 Binders Ureas Fluothiuron Inhbition of Photosynthesis at PSII - Serine 264 Binders Ureas Isoproturon Inhbition of Photosynthesis at Ureas PSII - Serine 264 Binders Isouron Inhbition of Photosynthesis at PSII - Serine 264 Binders Ureas Linuron Inhbition of Photosynthesis at Ureas PSII - Serine 264 Binders Metobenzuron Inhbition of Photosynthesis at PSII - Serine 264 Binders Ureas Metobromuron Inhbition of Photosynthesis at Ureas PSII - Serine 264 Binders Methabenzthiazuron Inhbition of Photosynthesis at PSII - Serine 264 Binders Ureas Metoxuron Inhbition of Photosynthesis at PSII - Serine 264 Binders Ureas Monolinuron Inhbition of Photosynthesis at PSII - Serine 264 Binders Ureas Monuron Inhbition of Photosynthesis at PSII - Serine 264 Binders Ureas Neburon Inhbition of Photosynthesis at PSII - Serine 264 Binders Ureas Parafluron Inhbition of Photosynthesis at PSII - Serine 264 Binders Ureas Siduron Inhbition of Photosynthesis at PSII - Serine 264 Binders Ureas Tebuthiuron

[0396] Inhbition of Photosynthesis at Ureas Thiazafluron PSII - Serine 264 Binders

[0397] Inhbition of Photosynthesis at

[0398] PSII - Serine 264 Binders Amides Chloranocryl=dicryl

[0399] Inhbition of Photosynthesis at

[0400] PSII - Serine 264 Binders Amides Pentanochlor

[0401] Inhbition of Photosynthesis at

[0402] PSII - Serine 264 Binders Amides Propanil

[0403] Inhbition of Photosynthesis at

[0404] PSII - Histidine 215 Binders Nitriles Bromofenoxim

[0405] Inhbition of Photosynthesis at

[0406] PSII - Histidine 215 Binders Nitriles Bromoxynil

[0407] Inhbition of Photosynthesis at

[0408] PSII - Histidine 215 Binders Nitriles Ioxynil

[0409] Inhbition of Photosynthesis at

[0410] PSII - Histidine 215 Binders Phenyl-pyridazines Pyridate

[0411] Inhbition of Photosynthesis at

[0412] PSII - Histidine 215 Binders Benzothiadiazinone Bentazon

[0413] PS I Electron Diversion Pyridiniums Cyperquat

[0414] PS I Electron Diversion Pyridiniums Diquat

[0415] PS I Electron Diversion Pyridiniums Morfamquat

[0416] PS I Electron Diversion Pyridiniums Paraquat

[0417] Inhibition of

[0418] Protoporphyrinogen Oxidase Diphenyl ethers Lactofen

[0419] Inhibition of

[0420] Protoporphyrinogen Oxidase Diphenyl ethers Acifluorfen

[0421] Inhibition of

[0422] Protoporphyrinogen Oxidase Diphenyl ethers Bifenox

[0423] Inhibition of

[0424] Protoporphyrinogen Oxidase Diphenyl ethers Chlornitrofen

[0425] Inhibition of

[0426] Protoporphyrinogen Oxidase Diphenyl ethers Fomesafen

[0427] Inhibition of

[0428] Protoporphyrinogen Oxidase Diphenyl ethers Fluorodifen

[0429] Inhibition of

[0430] Protoporphyrinogen Oxidase Diphenyl ethers Fluoroglycofen-ethyl

[0431] Inhibition of

[0432] Protoporphyrinogen Oxidase Diphenyl ethers Fluoronitrofen

[0433] Inhibition of

[0434] Protoporphyrinogen Oxidase Diphenyl ethers Nitrofen

[0435] Inhibition of

[0436] Protoporphyrinogen Oxidase Diphenyl ethers Oxyfluorfen

[0437] Inhibition of

[0438] Protoporphyrinogen Oxidase Diphenyl ethers Chlomethoxyfen Inhibition of

[0439] Protoporphyrinogen Oxidase Phenylpyrazoles Pyraflufen-ethyl

[0440] Inhibition of

[0441] Protoporphyrinogen Oxidase N-Phenyl-oxadiazolones Oxadiargyl

[0442] Inhibition of

[0443] Protoporphyrinogen Oxidase N-Phenyl-oxadiazolones Oxadiazon

[0444] Inhibition of

[0445] Protoporphyrinogen Oxidase N-Phenyl-triazolinones Azafenidin

[0446] Inhibition of

[0447] Protoporphyrinogen Oxidase N-Phenyl-triazolinones Carfentrazone-ethyl

[0448] Inhibition of

[0449] Protoporphyrinogen Oxidase N-Phenyl-triazolinones Sulfentrazone

[0450] Inhibition of N-Phenyl-imides (procide acitive

[0451] Protoporphyrinogen Oxidase form) Fluthiacet-methyl

[0452] Inhibition of

[0453] Protoporphyrinogen Oxidase N-Phenyl-imides Butafenacil

[0454] Inhibition of

[0455] Protoporphyrinogen Oxidase N-Phenyl-imides Saflufenacil

[0456] Inhibition of

[0457] Protoporphyrinogen Oxidase N-Phenyl-imides Pentoxazone

[0458] Inhibition of

[0459] Protoporphyrinogen Oxidase N-Phenyl-imides Chlorphthalim

[0460] Inhibition of

[0461] Protoporphyrinogen Oxidase N-Phenyl-imides Cinidon-ethyl

[0462] Inhibition of

[0463] Protoporphyrinogen Oxidase N-Phenyl-imides Flumiclorac-pentyl

[0464] Inhibition of

[0465] Protoporphyrinogen Oxidase N-Phenyl-imides Flumioxazin

[0466] Inhibition of

[0467] Protoporphyrinogen Oxidase N-Phenyl-imides Flumipropyn

[0468] Inhibition of

[0469] Protoporphyrinogen Oxidase N-Phenyl-imides Trifludimoxazin

[0470] Inhibition of

[0471] Protoporphyrinogen Oxidase N-Phenyl-imides Tiafenacil

[0472] Inhibition of

[0473] Protoporphyrinogen Oxidase Other Pyraclonil

[0474] Inhibition of Phytoene

[0475] Desaturase Phenyl ethers Beflubutamid

[0476] Inhibition of Phytoene

[0477] Desaturase Phenyl ethers Diflufenican

[0478] Inhibition of Phytoene

[0479] Desaturase Phenyl ethers Picolinafen

[0480] Inhibition of Phytoene

[0481] Desaturase N-Phenyl heterocycles Flurochloridone

[0482] Inhibition of Phytoene

[0483] Desaturase N-Phenyl heterocycles Norflurazon Inhibition of Phytoene Desaturase Diphenyl heterocycles Fluridone

[0484] Inhibition of Phytoene Desaturase Diphenyl heterocycles Flurtamone

[0485] Inhibition of Hydroxyphenyl Pyruvate Dioxygenase Triketones Mesotrione Inhibition of Hydroxyphenyl Pyruvate Dioxygenase Triketones Sulcotrione Inhibition of Hydroxyphenyl Pyruvate Dioxygenase Triketones Tembotrione Inhibition of Hydroxyphenyl Pyruvate Dioxygenase Triketones Tefuryltrione Inhibition of Hydroxyphenyl Pyruvate Dioxygenase Triketones Bicyclopyrone Inhibition of Hydroxyphenyl Pyruvate Dioxygenase Triketones Fenquinotrione Inhibition of Hydroxyphenyl Pyruvate Dioxygenase Triketones (procide) Benzobicyclon

[0486] Inhibition of Hydroxyphenyl Pyruvate Dioxygenase Pyrazoles (procide) Benzofenap Inhibition of Hydroxyphenyl Pyruvate Dioxygenase Pyrazoles Pyrasulfotole Inhibition of Hydroxyphenyl Pyruvate Dioxygenase Pyrazoles Topramezone Inhibition of Hydroxyphenyl Pyruvate Dioxygenase Pyrazoles (procide) Pyrazolynate Inhibition of Hydroxyphenyl Pyruvate Dioxygenase Pyrazoles (procide) Pyrazoxyfen Inhibition of Hydroxyphenyl Pyruvate Dioxygenase Pyrazoles Tolpyralate

[0487] Inhibition of Hydroxyphenyl Pyruvate Dioxygenase Isoxazoles Isoxaflutole

[0488] Inhibition of Homogentisate Solanesyltransferase Phenoxypyridazine Cyclopyrimorate

[0489] Inhibition of Deoxy-D-Xyulose Phosphate Synthase Isoxazolidinone Clomazone Inhibition of Deoxy-D-Xyulose Phosphate Synthase Isoxazolidinone Bixlozone

[0490] Inhibition of Enolpyruvyl Shikimate Phosphate Synthase Glycine Glyphosate

[0491] Inhibition of Glutamine Synthetase Phosphinic acids Glufosinate-ammonium Inhibition of Glutamine

[0492] Synthetase Phosphinic acids Bialaphos / bilanafos

[0493] Inhibition of Dihydropteroate Synthase Carbamate Asulam

[0494] Inhibition of Microtubule

[0495] Assembly Dinitroanilines Benefin=benfluralin

[0496] Inhibition of Microtubule

[0497] Assembly Dinitroanilines Butralin

[0498] Inhibition of Microtubule Dinitroanilines

[0499] Assembly Dinitramine

[0500] Inhibition of Microtubule

[0501] Assembly Dinitroanilines Ethalfluralin

[0502] Inhibition of Microtubule Dinitroanilines

[0503] Assembly Fluchloralin

[0504] Inhibition of Microtubule

[0505] Assembly Dinitroanilines Isopropalin

[0506] Inhibition of Microtubule

[0507] Assembly Dinitroanilines Nitralin

[0508] Inhibition of Microtubule

[0509] Assembly Dinitroanilines Prodiamine

[0510] Inhibition of Microtubule

[0511] Assembly Dinitroanilines Profluralin

[0512] Inhibition of Microtubule

[0513] Assembly Dinitroanilines Oryzalin

[0514] Inhibition of Microtubule

[0515] Assembly Dinitroanilines Pendimethalin

[0516] Inhibition of Microtubule

[0517] Assembly Dinitroanilines Trifluralin

[0518] Inhibition of Microtubule

[0519] Assembly Pyridines Dithiopyr

[0520] Inhibition of Microtubule

[0521] Assembly Pyridines Thiazopyr

[0522] Inhibition of Microtubule

[0523] Assembly Phosphoroamidates Butamifos

[0524] Inhibition of Microtubule

[0525] Assembly Phosphoroamidates DMPA

[0526] Inhibition of Microtubule

[0527] Assembly Benzoic acid Chlorthal-dimethyl=DCPA

[0528] Inhibition of Microtubule

[0529] Assembly Benzamides Propyzamide=pronamide

[0530] Inhibition of Microtubule

[0531] Organization Carbamates Barban

[0532] Inhibition of Microtubule

[0533] Organization Carbamates Carbetamide

[0534] Inhibition of Microtubule Carbamates Chlorbufam Organization

[0535] Inhibition of Microtubule

[0536] Organization Carbamates Chlorpropham

[0537] Inhibition of Microtubule

[0538] Organization Carbamates Propham

[0539] Inhibition of Microtubule

[0540] Organization Carbamates Swep

[0541] Inhibition of Cellulose

[0542] Synthesis T riazolocarboxamide Flupoxam

[0543] Inhibition of Cellulose

[0544] Synthesis Benzamides Isoxaben

[0545] Inhibition of Cellulose

[0546] Synthesis Alkylazines Triaziflam

[0547] Inhibition of Cellulose

[0548] Synthesis Alkylazines Indaziflam

[0549] Inhibition of Cellulose

[0550] Synthesis Nitriles Dichlobenil

[0551] Inhibition of Cellulose

[0552] Synthesis Nitriles Chlorthiamid

[0553] Uncouplers Dinitrophenols Dinosam

[0554] Uncouplers Dinitrophenols Dinoseb

[0555] Uncouplers Dinitrophenols DNOC

[0556] Uncouplers Dinitrophenols Dinoterb

[0557] Uncouplers Dinitrophenols Etinofen

[0558] Uncouplers Dinitrophenols Medinoterb

[0559] Inhibition of Very Long-Chain

[0560] Fatty Acid Synthesis Azolyl-carboxamides Cafenstrole

[0561] Inhibition of Very Long-Chain

[0562] Fatty Acid Synthesis Azolyl-carboxamides Fentrazamide Inhibition of Very Long-Chain Fatty Acid Synthesis Azolyl-carboxamides Ipfencarbazone

[0563] Inhibition of Very Long-Chain

[0564] Fatty Acid Synthesis a-Thioacetamides Anilofos

[0565] Inhibition of Very Long-Chain

[0566] Fatty Acid Synthesis a-Thioacetamides Piperophos

[0567] Inhibition of Very Long-Chain

[0568] Fatty Acid Synthesis Isoxazolines Pyroxasulfone

[0569] Inhibition of Very Long-Chain

[0570] Fatty Acid Synthesis Isoxazolines Fenoxasulfone

[0571] Inhibition of Very Long-Chain Oxiranes Indanofan Fatty Acid Synthesis Inhibition of Very Long-Chain Fatty Acid Synthesis Oxiranes Tridiphane

[0572] Inhibition of Very Long-Chain Fatty Acid Synthesis a-Chloroacetamides Acetochlor Inhibition of Very Long-Chain Fatty Acid Synthesis a-Chloroacetamides Alachlor Inhibition of Very Long-Chain Fatty Acid Synthesis a-Chloroacetamides Allidochlor=CDAA Inhibition of Very Long-Chain Fatty Acid Synthesis a-Chloroacetamides Butachlor Inhibition of Very Long-Chain Fatty Acid Synthesis a-Chloroacetamides Butenachlor Inhibition of Very Long-Chain Fatty Acid Synthesis a-Chloroacetamides Delachlor Inhibition of Very Long-Chain Fatty Acid Synthesis a-Chloroacetamides Diethatyl-ethyl Inhibition of Very Long-Chain Fatty Acid Synthesis a-Chloroacetamides Dimethachlor Inhibition of Very Long-Chain Fatty Acid Synthesis a-Chloroacetamides Dimethenamid Inhibition of Very Long-Chain Fatty Acid Synthesis a-Chloroacetamides Metazachlor Inhibition of Very Long-Chain Fatty Acid Synthesis a-Chloroacetamides Metolachlor Inhibition of Very Long-Chain Fatty Acid Synthesis a-Chloroacetamides Pethoxamid Inhibition of Very Long-Chain Fatty Acid Synthesis a-Chloroacetamides Pretilachlor Inhibition of Very Long-Chain Fatty Acid Synthesis a-Chloroacetamides Propachlor Inhibition of Very Long-Chain Fatty Acid Synthesis a-Chloroacetamides Propisochlor Inhibition of Very Long-Chain Fatty Acid Synthesis a-Chloroacetamides Prynachlor Inhibition of Very Long-Chain Fatty Acid Synthesis a-Chloroacetamides Thenylchlor

[0573] Inhibition of Very Long-Chain

[0574] Fatty Acid Synthesis a-Oxyacetamides Mefenacet

[0575] Inhibition of Very Long-Chain

[0576] Fatty Acid Synthesis a-Oxyacetamides Flufenacet

[0577] Inhibition of Very Long-Chain Fatty Acid Synthesis Thiocarbamates Butylate Inhibition of Very Long-Chain Fatty Acid Synthesis Thiocarbamates Cycloate Inhibition of Very Long-Chain Fatty Acid Synthesis Thiocarbamates Dimepiperate Inhibition of Very Long-Chain Fatty Acid Synthesis Thiocarbamates EPTC

[0578] Inhibition of Very Long-Chain Thiocarbamates Esprocarb Fatty Acid Synthesis

[0579] Inhibition of Very Long-Chain

[0580] Fatty Acid Synthesis Thiocarbamates Molinate

[0581] Inhibition of Very Long-Chain

[0582] Fatty Acid Synthesis Thiocarbamates Orbencarb

[0583] Inhibition of Very Long-Chain

[0584] Fatty Acid Synthesis Thiocarbamates Pebulate

[0585] Inhibition of Very Long-Chain

[0586] Fatty Acid Synthesis Thiocarbamates Prosulfocarb

[0587] Inhibition of Very Long-Chain

[0588] Fatty Acid Synthesis Thiocarbamates Thiobencarb (=Benthiocarb)

[0589] Inhibition of Very Long-Chain

[0590] Fatty Acid Synthesis Thiocarbamates Tiocarbazil

[0591] Inhibition of Very Long-Chain

[0592] Fatty Acid Synthesis Thiocarbamates Tri-allate

[0593] Inhibition of Very Long-Chain

[0594] Fatty Acid Synthesis Thiocarbamates Vernolate

[0595] Inhibition of Very Long-Chain

[0596] Fatty Acid Synthesis Benzofurans Benfuresate

[0597] Inhibition of Very Long-Chain

[0598] Fatty Acid Synthesis Benzofurans Ethofumesate

[0599] Auxin Mimics Pyridine-carboxylates Picloram

[0600] Auxin Mimics Pyridine-carboxylates Clopyralid

[0601] Auxin Mimics Pyridine-carboxylates Aminopyralid

[0602] Auxin Mimics Pyridine-carboxylates Halauxifen

[0603] Auxin Mimics Pyridine-carboxylates Florpyrauxifen

[0604] Auxin Mimics Pyridyloxy-carboxylates Triclopyr

[0605] Auxin Mimics Pyridyloxy-carboxylates Fluroxypyr

[0606] Auxin Mimics Phenoxy-carboxylates 2,4,5-T

[0607] Auxin Mimics Phenoxy-carboxylates 2.4-D

[0608] Auxin Mimics Phenoxy-carboxylates 2.4-DB

[0609] Auxin Mimics Phenoxy-carboxylates Clomeprop

[0610] Auxin Mimics Phenoxy-carboxylates Dichlorprop

[0611] Auxin Mimics Phenoxy-carboxylates Fenoprop

[0612] Auxin Mimics Phenoxy-carboxylates Mecoprop

[0613] Auxin Mimics Phenoxy-carboxylates MCPA

[0614] Auxin Mimics Phenoxy-carboxylates MCPB

[0615] Auxin Mimics Benzoates Dicamba

[0616] Auxin Mimics Benzoates Chloramben

[0617] Auxin Mimics Benzoates TBA Auxin Mimics Quinoline-carboxylates Quinclorac

[0618] Auxin Mimics Quinoline-carboxylates Quinmerac

[0619] Auxin Mimics Pyrimidine-carboxylates Aminocyclopyrachlor

[0620] Auxin Mimics Other Benazolin-ethyl

[0621] Auxin Mimics Phenyl carboxylates Chlorfenac=fenac

[0622] Auxin Mimics Phenyl carboxylates Chlorfenprop

[0623] Auxin Transport Inhibitor Aryl-carboxylates Naptalam

[0624] Auxin Transport Inhibitor Aryl-carboxylates Diflufenzopyr-sodium

[0625] Inhibition of Fatty Acid

[0626] Thioesterase Benzyl ether Cinmethylin

[0627] Inhibition of Fatty Acid

[0628] Thioesterase Benzyl ether Methiozolin

[0629] Inhibition of Serine-Threonine

[0630] Protein Phosphatase Other Endothal

[0631] Inhibition of Solanesyl

[0632] Diphosphate Synthase Diphenyl ether Aclonifen

[0633] Inhibition of Lycopene

[0634] Cyclase Triazole Amitrole

[0635] Unknown Bromobutide

[0636] Unknown Cumyluron

[0637] Unknown Difenzoquat

[0638] Unknown DSMA

[0639] Unknown Dymron=Daimuron

[0640] Unknown Etobenzanid

[0641] Unknown Arylaminopropionic acid Flamprop-m

[0642] Unknown Fosamine

[0643] Unknown Methyldymron

[0644] Unknown Monalide

[0645] Unknown MSMA

[0646] Unknown Oleic acid

[0647] Unknown Oxaziclomefone

[0648] Unknown Pelargonic acid

[0649] Unknown Pyributicarb

[0650] Unknown Quinoclamine

[0651] Unknown Acetamides Diphenamid Unknown Acetamides Naproanilide

[0652] Unknown Acetamides Napropamide

[0653] Unknown Benzamide Tebutam

[0654] Unknown Phosphorod ithioate Bensulide

[0655] Unknown Chlorocarbonic acids Dalapon

[0656] Unknown Chlorocarbonic acids Flupropanate

[0657] Unknown Chlorocarbonic acids TCA

[0658] Unknown T rifluoromethanesulfonanilides Mefluidide

[0659] Unknown T rifluoromethanesulfonanilides Perfluidone

[0660] Unknown CAMA

[0661] Unknown Cacodylic acid

[0662] APPENDIX 3

[0663]

[0664]

[0665] In view of the many possible embodiments to which the principles of the disclosed invention may be applied, it should be recognized that the illustrated embodiments are only preferred examples of the invention and should not be taken as limiting the scope of the invention. Rather, the scope of the invention is defined by the following claims. We therefore claim as our invention all that comes within the scope and spirit of these claims.

Claims

We claim:

1. A method for inhibiting apyrase, comprising contacting the apyrase with a compound of the formulaor an agriculturally acceptable salt, solvate and / or N-oxide thereof, whereinZ1and Z2are each independently selected from a group consisting of hydrogen, Ci-6 alkyl; or Z1together with Z2and the atoms to which Z1and Z2are attached, forms a 5- or 6- membered ring optionally substituted with one or more of Ra; wherein the 5- or 6-membered ring is optionally a heterocyclyl ring with one or more heteroatom groups selected from O, N, -N(Re)-, S, -S(0)-, -SO2-;R1is independently selected from a group consisting of hydrogen, C1-6 alkyl, optionally substituted with one or more Ra;R2is selected from hydrogen and C1-6 alkyl;X is -(CRaRb)n-Y;Y is selected from the group consisting of Ra, Rb, Rasubstituted with one or more of the same or different R8, Raor Rb, -0Rasubstituted with one or more of the same or different Raor Rb; -S(O)R8, -S(O)2R8, -N(Rd)S(O)2R8, -S(O)NRCRC, -S(O)2-NRCRC, -OS(O)Rd, -OS(O)2Rd, -OS(O)2ORd, -C(O)OR8, -C(O)R8, -OC(O)R8, -C(O)NRCRC, -NReRc, -N(Rd)-C(O)R8, -N(Rd)-C(O)OR8. N(Rd)-C(O)NReRc, -SR8.-(CH2)mR8, -OC(O)-(CH2)m-C(O)R8, -CHRCRC;R8is selected from the group consisting of Ra, Rb, Rasubstituted with one or more of the same or different Raor Rb, -CH2Rasubstituted with one or more of the same or different Raor Rb, -0Rasubstituted with one or more of the same or different Raor Rb; each Rais independently selected from hydrogen, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 haloalkyl, C3-8 cycloalkyl, Ce-io aryl, C5-10 heteroaryl, Ce-i6 arylalkyl, 2-6 membered heteroalkyl and 3-8 membered heterocyclylalkyl;Rbis independently selected from the group consisting of =0, -0Ra, halogen, C1-3 haloalkyloxy, -OCF3, =S, -SRd, =NRd, =NORd, -NRCRC, -SF5, halogen, -CF3, -CN, -N02, -S(O)Rd, -S(O)2Rd, -S(O)2ORd, -N(H)S(O)2Rd, -S(O)NRCRC, -S(O)2NReRc, -OS(O)Rd. -OS(O)2Rd, -OS(O)2ORd, -OS(O)2NRCRC, -C(O)Rd, -C(O)ORd, -C(O)NRCRC, -C(NH)NRCRC, -C(NRa)NRcRc, -C(N0H)Ra, -C(NOH)NRCRC, -OC(O)Rd, -OC(O)ORd, -OC(O)NRCRC. -OC(NH)NRCRC, -0C(NRa)NRcRc, -[NHC(O)]„Rd, -[NRaC(0)]„Rd, -[NHC(O)]„ORd, -[NRaC(O)]„ORd, -[NHC(O)]„NRCRC, -[NRaC(O)]„NRcRc, -[NHC(NH)]„NRCRCand -[NRaC(NRa)]„NRcRc; each Rcis hydrogen, R8, or, alternatively, two Rcare taken together with the atom to which they are bonded to form a 5 to 10-membered cycloalkyl or heterocyclylalkyl which may optionally be substituted with one or more of the same or different Regroups; each Rdis independently hydrogen or C1-6 alkyl; each Reis independently Rhor Rd; each m is independently an integer from 0 to 2; and each n is independently an integer from 0 to 2; provided that the compound is not2. The method of claim 1, wherein the compound has the formula:

3. The method of claim 1, wherein the compound has the formula:

4. The method of any one of claims 1 - 3, wherein at least one of Z1and Z2is hydrogen.

5. The method of any one of claims 1 - 4, wherein Z1and Z2are both hydrogen.

6. The method of any one of claims 1 - 4, wherein at least one of Z1and Z2is Ci-6 alkyl.

7. The method of claim 1 , wherein Z1and Z2are both Ci-6 alkyl.

8. The method of claim 1, wherein Z1together with Z2forms a 6-membered ring.

9. The method of claim 1 or 8, wherein Z1and Z2together form an aliphatic ring.

10. The method of claim 1 or 8, wherein Z1and Z2together form a heteroaliphatic ring.

11. The method of claim 1 or 8, wherein Z1and Z2together form an aromatic ring.

12. The method of claim 1 or 8, wherein Z1and Z2together form a heteroaromatic ring.

13. The method of any one of claims 1 - 8, wherein Z1together with Z2forms a ring selected from:

14. The method of any one of claims 1, 2, 8, 9 and 13, wherein the compound has the formula:

16. The method of any one of claims 1, 2, 8 and 10, wherein the compound has the formula:

17. The method of any one of claims 1, 3, 8 and 10, wherein the compound has the formula:12818. The method of any one of claims 1, 2, 8 and 10, wherein the compound has the formula: any one of claims 1, 3, 8 and 10, wherein the compound has the formula:

20. The method of any one of claims 1, 2, 8, 11 and 13, wherein the compound has the formula:

21. The method of any one of claims 1, 3, 8, 11 and 13, wherein the compound has the formula:12922. The method of any one of claims 1, 2, 8, 12 and 13, wherein the compound has the formula:

23. The method of any one of claims 1, 3, 8, 12 and 13, wherein the compound has the formula:

24. The method of any one of claims 1 - 23, wherein R1is hydrogen.

25. The method of any one of claims 1 - 23, wherein R1is Ci-6 alkyl.

26. The method of any one of claims 1 - 23, wherein R1is Ci-6 alkyl substituted with one or more Ra.

27. The method of any one of claims 1 - 26, wherein R2is hydrogen.

28. The method of any one of claims 1 - 26, wherein R2is Ci-6 alkyl.13029. The method of any one of claims 1 - 28, wherein Y is selected from the group consisting of13130. The method of claim 1 , wherein the compound is selected from the group consisting of: ethyl 2-(3-(N-(3-chlorophenyl)sulfamoyl)benzamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3- carboxylate2-((3-(isopropoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2- oxoethyl pyrazine-2-carboxylate2-((3-(ethoxycarbonyl)-4,5.6.7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl picolinate ethyl 2-(2-(phenylamino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(cyclohexyl(methyl)amino)acetamido)-5,6-dihydro-4H-cyclopenta[b]thiophene-3- carboxylate2-((3-(isopropoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethylisonicotinate 2-((3-(ethoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl furan-2- carboxylate ethyl 2-(2-(4-fluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(o-tolyloxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(tert-butylamino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate134isopropyl 2-(2-((4-hydroxy-6-oxo-l-propyl-l ,6-dihydropyrimidin-2-yl)thio)acetamido)-4,5,6,7- tetrahydrobenzo [b]thiophene-3-carboxylate2-((3-(isopropoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 2-(lH- pyrazol- 1 -yl)nicotinate2-((3-(isopropoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl furan-2- carboxylate isopropyl 2-(2-(3,5-dimethyl-4-nitro-lH-pyrazol-l-yl)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(quinolin-8-yloxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(4-methoxyphenoxy)acetamido)thiophene-3-carboxylate isopropyl 2-(2-((4-oxo-4-(thiophen-2-yl)butanoyl)oxy)acetamido)-4, 5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate isopropyl 2-(2-((5-oxo-4-propyl-4,5-dihydro-lH-l,2,4-triazol-3-yl)thio)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate2-((3-(isopropoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 2-(tert- butyl)- 1 ,2,3,4-tetrahydroacridine-9-carboxylate ethyl 2-(2-cyclopentylacetamido)-4,5-dimethylthiophene-3-carboxylate isopropyl 2-(2-((5,7-dimethyl-[l,2,4]triazolo[4,3-a]pyrimidin-3-yl)thio)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(3-fluorophenoxy)acetamido)thiophene-3-carboxylate ethyl 2-(2-(thieno[2,3-d]pyrimidin-4-ylthio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3- carboxylate ethyl 2-(2-phenylacetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate isopropyl 2-(2-(2-((methylsulfonyl)methyl)-lH-benzo[d]imidazol-l-yl)acetamido)-4, 5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(benzo[d]oxazol-2-ylthio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate isopropyl 2-(2-((4-(2-methoxyphenyl)-4H- 1,2,4- triazol-3-yl)thio)acetamido)-4, 5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate isopropyl 2-(2-((3-(4-methyl-2-oxothiazol-3(2H)-yl)propanoyl)oxy)acetamido)-4,5,6,7-135tetrahydrobenzo[b]thiophene-3-carboxylate tert-butyl 2-(3-bromoisonicotinamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate isopropyl 2-(2-((5-amino-4H-l,2,4-triazol-3-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(naphthalen-2-yloxy)acetamido)thiophene-3-carboxylate isopropyl 2-(2-((l-(3-fluorophenyl)cyclopentane- l-carbonyl)oxy)acetamido)-4, 5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate isopropyl 2-(2-(6,7-dimethoxy-4-oxoquinazolin-3(4H)-yl)acetamido)-4, 5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate isopropyl 2-(5-((4-chloro-3,5-dimethyl- lH-pyrazol-l-yl)methyl)furan-2-carboxamido)-4, 5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate isopropyl 2-(2-((4-amino-5-(p-tolyl)-4H- 1 ,2, 4-triazol-3-yl)thio)acetamido)-4, 5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate isopropyl 6-methyl-2-(5-methylpyrazine-2-carboxamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3- carboxylate ethyl 2-(2-((4-fluorophenyl)amino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate tert-butyl 6,6-dimethyl-2-(2-(methylsulfonyl)propanamido)-4,5.6.7-tetrahydrobenzo[b]thiophene-3- carboxylate ethyl 2-(2-(methyl(phenyl)amino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate tert-butyl 2-(2-(lH-pyrazol-l-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-cyanoacetamido)-4,5-dimethylthiophene-3-carboxylate isopropyl 2-(l-methyl-lH-l,2,3-triazole-5-carboxamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3- carboxylate tert-butyl 2- (2- (4-oxopyrazolo [ 1 ,5 -d] [ 1 ,2,4] triazin-5 (4H)-yl)acetamido)-4,5 ,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate tert-butyl 2-(2-ethoxyacetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 4,5-dimethyl-2-(2-(phenylthio)acetamido)thiophene-3-carboxylate isopropyl 2-(2-((4-methoxybenzyl)amino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3- carboxylate136oxalic acid salt of isopropyl 2-(2-((3-hydroxypropyl)amino)acetamido)-4, 5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate2-((3-(ethoxycarbonyl)-4,5-dimethylthiophen-2-yl)amino)-2-oxoethyl 5-methylisoxazole-4- carboxylate2-((3-(isopropoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 6-oxo- l,4,5,6-tetrahydropyridazine-3-carboxylate isopropyl 2-(2-((4-allyl-5-methyl-4H-l,2,4-triazol-3-yl)thio)acetamido)-4,5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-((2-methoxyphenyl)amino)acetamido)-4,5-dimethylthiophene-3-carboxylate ethyl 2-(2-((5-methyl-l,3,4-thiadiazol-2-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3- carboxylate ethyl 2-(2-(4-chlorophenoxy)acetamido)-4,5-dimethylthiophene-3-carboxylate ethyl 2-(2-(3-cyanophenoxy)acetamido)thiophene-3-carboxylate ethyl 2-(2-((5-amino-l,3,4-thiadiazol-2-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3- carboxylate ethyl 4,5-dimethyl-2-(3-(phenylthio)propanamido)thiophene-3-carboxylate2-((3-(isopropoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 5- methylpyrazine-2-carboxylate ethyl 2-(2-((l,3,4-thiadiazol-2-yl)thio)acetamido)thiophene-3-carboxylate ethyl 2-(2-(quinazolin-4-ylthio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate tert-butyl 2-(l-acetylpyrrolidine-3-carboxamido)-6.6-dimethyl-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate2-((3-(isopropoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 2,5- dimethylfuran-3-carboxylate oxalic acid salt of isopropyl 2-(2-(4-methylpiperazin-l-yl)acetamido)-4, 5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate tert-butyl 2-(2-oxo-2-(l, 3, 5 -trimethyl- lH-pyrazol-4-yl)acetamido)-4, 5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylateisopropyl 2-(2-(4-(furan-2-carbonyl)piperazin-l-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate oxalic acid salt of isopropyl 2-(2-(ethylamino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3- carboxylate ethyl 4,5-dimethyl-2-(2-(thiophen-2-yl)acetamido)thiophene-3-carboxylate isopropyl 2-(2-(2-(4-oxo-3,4-dihydrophthalazin- l-yl)acetoxy)acetamido)-4, 5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate isopropyl 2-(2-(lH-l,2,4-triazol-l-yl)acetamido)-4,5,6.7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(naphthalen-l-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(p-tolylamino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(adamantan-l-yl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-((5-amino-4H-l ,2,4-triazol-3-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3- carboxylate2-((3-(ethoxycarbonyl)-4,5-dimethylthiophen-2-yl)amino)-2-oxoethyl 5-methylfuran-2-carboxylate isopropyl 6-methyl-2-(2-(4-(4-nitrophenyl)piperazin-l-yl)acetamido)-4, 5,6,7- tetrahydrobenzo[b]thiophene-3-carboxylate2-((3-(ethoxycarbonyl)-4,5-dimethylthiophen-2-yl)amino)-2-oxoethyl isonicotinate l-(2-((3-(ethoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl)cyclopentane-1 -carboxylic acid ethyl 2-(2-((l-methyl-lH-tetrazol-5-yl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3- carboxylate2-((3-(isopropoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 2- hydroxyquinoline-4-carboxylate ethyl 2-(2-([l,2,4]triazolo[4,3-a]pyridin-3-ylthio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3- carboxylate ethyl 2-(3-morpholinopropanamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate4-((2-((3-(ethoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2- oxoethoxy)carbonyl)pyridine 1 -oxide ethyl 2-(3-(pyrrolidin-l-yl)propanamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylateoxalic acid salt2-((3-(ethoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 5-methylfuran-2- carboxylate ethyl 2-(2-(l-methyl-3,4-dihydropyrrolo[l,2-a]pyrazin-2(lH)-yl)acetamido)thiophene-3-carboxylate ethyl 2-(2-(2,4-difluorophenoxy)acetamido)-4,5-dimethylthiophene-3-carboxylate ethyl 2-acetamido-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-cyanoacetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 4,5-dimethyl-2-(2-(m-tolylamino)acetamido)thiophene-3-carboxylate ethyl 2-(4-methoxy-4-oxobutanamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate2-((3-(ethoxycarbonyl)-4,5-dimethylthiophen-2-yl)amino)-2-oxoethyl pyrazine-2-carboxylate ethyl 2-(2-(cycloheptylamino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-((3,5-dimethylphenyl)amino)acetamido)-4,5-dimethylthiophene-3-carboxylate ethyl 2-(2-((2,6-difluorobenzoyl)oxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 4,5-dimethyl-2-(2-(o-tolyloxy)acetamido)thiophene-3-carboxylate2-((3-(isopropoxycarbonyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)amino)-2-oxoethyl 2-(allylamino)thiazole-4-carboxylate2-((3-(ethoxycarbonyl)-4,5-dimethylthiophen-2-yl)amino)-2-oxoethyl picolinate ethyl 2-(2-(benzoyloxy)acetamido)-4,5-dimethylthiophene-3-carboxylate ethyl 2-(2-((4-(methoxycarbonyl)phenyl)amino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3- carboxylate ethyl 2-(2-(benzylthio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-((l-methyl-4,5-dihydro-lH-imidazol-2-yl)thio)acetamido)thiophene-3-carboxylate ethyl 2-(2-(azepan-l-yl)acetamido)-4,5-dimethylthiophene-3-carboxylate ethyl 2-(2-((4-chlorobenzyl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-((l,3,4-thiadiazol-2-yl)thio)acetamido)-4,5-dimethylthiophene-3-carboxylate oxalic acid salt of ethyl 2-(2-(butylamino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3- carboxylate ethyl 2-(2-((3-(trifluoromethyl)phenyl)amino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3- carboxylate139ethyl 2-(2-(2,6-dimethylmorpholino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(4-fluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(4-fluorophenoxy)-N-methylacetamido)-4,5.6.7-tetrahydrobenzo[b]thiophene-3- carboxylate2-(2-(4-fluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid methyl 2-(2-(4-fluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate isopropyl 2-(2-(4-fluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate tert-butyl 2-(2-(4-fluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(4-fluorophenoxy)-2-methylpropanamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3- carboxylate ethyl 2-(2-((4-fluorophenyl)(methyl)amino)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3- carboxylate ethyl 2-(2-((4-fluorophenyl)thio)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-((4-fluorophenyl)sulfbnyl)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(3-(4-fluorophenyl)propanamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-((((4-fluorobenzyl)oxy)carbonyl)amino)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(4-chlorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(4-nitrophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(p-tolyloxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(4-methoxyphenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(3-fluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(2-fluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(2,4-difluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(3-chloro-4-fluorophenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(benzo[d][l,3]dioxol-5-yloxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3- carboxylate ethyl 2-(2-(4-(trifluoromethoxy)phenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3- carboxylate140ethyl 2-(2-(3-(trifluoromethyl)phenoxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3- carboxylate ethyl 2-(2-(pyridin-4-yloxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(pyridin-3-yloxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(pyridin-2-yloxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-((tetrahydro-2H-pyran-4-yl)oxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3- carboxylate ethyl 2-(2-(4-fluorophenoxy)acetamido)-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylate ethyl 2-(2-(4-fluorophenoxy)acetamido)benzo[b]thiophene-3-carboxylate ethyl 2-(2-(4-fluorophenoxy)acetamido)-5-methyl-4-oxo-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-3- carboxylate ethyl 2-(2-(4-fluorophenoxy)acetamido)-4,7-dihydro-5H-thieno[2,3-c]thiopyran-3-carboxylate 6,6- dioxide ethyl 2-(2-phenoxyacetamido)-6,7-dihydro-4H-thieno[3,2-c]pyran-3-carboxylate ethyl 2-(2-phenoxyacetamido)benzo[b]thiophene-3-carboxylate ethyl 5-methyl-4-oxo-2-(2-phenoxyacetamido)-4,5.6.7-tetrahydrothieno[3,2-c]pyridine-3-carboxylate ethyl 2-(2-phenoxyacetamido)-6,7-dihydro-4H-thieno[3,2-c]thiopyran-3-carboxylate 5,5-dioxide ethyl 2-(2-((2-methylbenzoyl)oxy)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(pyrazine-2-carboxamido)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate ethyl 2-(2-(N-methylpyrazine-2-carboxamido)acetamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3- carboxylate; and ethyl 2-(2-(4-fluorophenoxy)acetamido)-4,7-dihydro-5H-thieno[2,3-c]thiopyran-3-carboxylate, or a combination thereof.

31. The method of any one of claims 1 - 30, wherein contacting the apyrase comprises treating a crop with the compound.

32. The method of claim 31, further comprising treating the crop with a pesticide.14133. The method of claim 32, wherein the pesticide is selected from acaricides, fungicides, herbicides, insecticides, molluscicides, nematocides, or a combination thereof.

34. The method of claim 33, wherein the pesticide comprises a fungicide.

35. The method of claim 34, further comprising treating the crop with a fungicide selected from selected from benzimidazoles, dicarboximides, phenylpyrroles, anilinopyrimidines, hydroxy anilides, carboxamides, phenyl amides, phosphonates, cinnamic acids, oxysterol binding protein inhibitors (OSBPI), triazole carboxamides, cymoxanil, carbamates, benzamides, demethylation inhibiting piperazines, demethylation inhibiting pyrimidines, demethylation inhibiting azoles, including imidazoles and triazoles, such as cyproconazole, difenoconazole, fenbuconazole, flutriafol, mefentrifluconazole, metconazole, ipconazole, prothioconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole. morpholines, cyflufenamid, metrafenone, pyriofenone, strobilurins, copper ammonium complex, copper hydroxide, copper oxide, copper oxychloride, copper sulfate, sulfur, lime sulfur, ethylenebisdithiocarbamates, aromatic hydrocarbons, phthalimides, guanidines, polyoxins, fluazinam, thiazolidines and combinations thereof.

36. A composition, comprising a fungicide; a compound of the formulaor an agriculturally acceptable salt, solvate and / or N-oxide thereof, whereinZ1and Z2are each independently selected from a group consisting of hydrogen, Ci-6 alkyl; or Z1together with Z2and the atoms to which Z1and Z2are attached, forms a 5- or 6- membered ring optionally substituted with one or more of Ra;1H- ,wherein the 5- or 6-membered ring is optionally a heterocyclyl ring with one or more heteroatom groups selected from O, N, -N(Re)-, S, -S(0)-, -SO2-;R1is independently selected from a group consisting of hydrogen, C1-6 alkyl, optionally substituted with one or more Ra;R2is selected from hydrogen and C1-6 alkyl;X is -(CRaRb)n-Y;Y is selected from the group consisting of Ra, Rb, Rasubstituted with one or more of the same or different R8, Raor Rb, -0Rasubstituted with one or more of the same or different Raor Rb; -S(O)R8, -S(O)2R8, -N(Rd)S(O)2R8, -S(O)NRCRC, -S(O)2-NRCRC, -OS(O)Rd, -OS(O)2Rd, -OS(O)2ORd, -C(O)OR8, -C(O)R8, -OC(O)R8, -C(O)NRCRC, -NRCRC, -N(Rd)-C(O)R8, -N(Rd)-C(O)OR8, N(Rd)-C(O)NRcRc, -SR8. -(CH2)mR8, -OC(O)-(CH2)m-C(O)R8, -CHRCRC;R8is selected from the group consisting of Ra, Rb, Rasubstituted with one or more of the same or different Raor Rb, -CH2Rasubstituted with one or more of the same or different Raor Rb, -0Rasubstituted with one or more of the same or different Raor Rb; each Rais independently selected from hydrogen, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 haloalkyl, C3-8 cycloalkyl, Ce-io aryl, C5-10 heteroaryl, Ce-16 arylalkyl, 2-6 membered heteroalkyl and 3-8 membered heterocyclylalkyl;Rbis independently selected from the group consisting of =0, -0Ra, halogen, C1-3 haloalkyloxy, -OCF3, =S, -SRd, =NRd, =N0Rd, -NRCRC, -SF5, halogen, -CF3, -CN, -N02, -S(O)Rd, -S(O)2Rd, -S(O)2ORd, -N(H)S(O)2Rd, -S(O)NRCRC, -S(O)2NRCRC, -OS(O)Rd, -OS(O)2Rd. -OS(O)2ORd, -OS(O)2NRCRC, -C(O)Rd, -C(O)ORd, -C(0)NReRc, -C(NH)NRCRC, -C(NRa)NRcRc, -C(N0H)Ra, -C(NOH)NRCRC, -OC(O)Rd, -OC(O)ORd, -0C(0)NRcRc, -OC(NH)NRCRC, -0C(NRa)NRcRc, -[NHC(O)]„Rd, -[NRaC(0)]„Rd, -[NHC(O)]„ORd, -[NRaC(O)]„ORd. -[NHC(O)]„NRCRC. -[NRaC(O)]„NRcRc, -[NHC(NH)]„NRCRCand -[NRaC(NRa)]„NRcRc; each Rcis hydrogen, R8, or, alternatively, two Rcare taken together with the atom to which they are bonded to form a 5 to 10-membered cycloalkyl or heterocyclylalkyl which may optionally be substituted with one or more of the same or different Regroups;143each Rdis independently hydrogen or Ci-6 alkyl; each Reis independently Rhor Rd; each m is independently an integer from 0 to 2; and each n is independently an integer from 0 to 2; and a phytologically acceptable carrier.

37. The composition of claim 36, wherein the composition comprises from about 1 to about 80 weight percent of the compound.

38. The composition of claim 37, wherein the composition is a suspension formulation.

39. The composition of claim 37, wherein the composition comprises from about 1 to about 50 weight percent of the compound.

40. The composition of claim 39, further comprising sodium polycarboxylate.

41. The composition of claim 40, further comprising biocides.

42. The composition of claim 41, further comprising organosilicone antifoam emulsion.

43. The composition of claim 42, wherein the composition is a wettable powder.

44. The composition of claim 43, wherein the composition is an emulsifiable concentrate.

45. The composition of claim 44, further comprising tristyrylphenol ethoxylates.

46. The composition of claim 36, wherein the composition is an oil dispersible concentrate.

47. A pesticidal composition, comprising144a pesticide; a compound of the formulaor an agriculturally acceptable salt, solvate and / or N-oxide thereof, whereinZ1and Z2are each independently selected from a group consisting of hydrogen, Ci-6 alkyl; or Z1together with Z2and the atoms to which Z1and Z2are attached, forms a 5- or 6- membered ring optionally substituted with one or more of Ra; wherein the 5- or 6-membered ring is optionally a heterocyclyl ring with one or more heteroatom groups selected from O, N, -N(Re)-. S, -S(0)-, -SO2-;R1is independently selected from a group consisting of hydrogen, C1-6 alkyl, optionally substituted with one or more Ra;R2is selected from hydrogen and C1-6 alkyl;X is -(CRaRb)n-Y;Y is selected from the group consisting of Ra, Rb, Rasubstituted with one or more of the same or different R8, Raor Rb, -0Rasubstituted with one or more of the same or different Raor Rb; -S(O)R8, -S(O)2R8, -N(Rd)S(O)2R8, -S(O)NRCRC, -S(O)2-NRCRC, -OS(O)Rd, -OS(O)2Rd, -OS(O)2ORd, -C(O)OR8, -C(O)R8, -OC(O)R8, -C(O)NRCRC, -NRCRC, -N(Rd)-C(O)R8, -N(Rd)-C(O)OR8, N(Rd)-C(O)NRcRc, -SR8, -(CH2)mR8, -OC(O)-(CH2)m-C(O)R8, -CHRCRC;R8is selected from the group consisting of Ra, Rb, Rasubstituted with one or more of the same or different Raor Rb, -CH2Rasubstituted with one or more of the same or different Raor Rb, -0Rasubstituted with one or more of the same or different Raor Rb; each Rais independently selected from hydrogen, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 haloalkyl, C3-8 cycloalkyl, Ce-io aryl, C5-10 heteroaryl, Ce-16 arylalkyl, 2-6 membered heteroalkyl and 3-8 membered heterocyclylalkyl;Rbis independently selected from the group consisting of =0, -0Ra, halogen, C1-3 haloalkyloxy, -OCF3, =S, -SRd, =NRd, =N0Rd, -NRCRC, -SF5, halogen, -CF3, -CN, -N02,1H-J-S(O)Rd, -S(O)2Rd, -S(O)2ORd, -N(H)S(O)2Rd, -S(O)NRCRC, -S(O)2NRCRC, -OS(O)Rd, -OS(O)2Rd, -OS(O)2ORd, -OS(O)2NRCRC, -C(O)Rd, -C(O)ORd, -C(O)NRCRC, -C(NH)NRCRC, -C(NRa)NRcRc, -C(NOH)Ra, -C(NOH)NRCRC, -OC(O)Rd, -OC(O)ORd,-OC(O)NRCRC, -OC(NH)NRCRC, -OC(NRa)NRcRc, -[NHC(O)]„Rd, -[NRaC(O)]„Rd, -[NHC(O)]„ORd, -[NRaC(O)]„ORd, -[NHC(O)]„NRCRC, -[NRaC(O)]„NRcRc, -[NHC(NH)]„NRCRCand -[NRaC(NRa)]„NRcRc; each Rcis hydrogen, R8, or, alternatively, two Rcare taken together with the atom to which they are bonded to form a 5 to 10-membered cycloalkyl or heterocyclylalkyl which may optionally be substituted with one or more of the same or different Regroups; each Rdis independently hydrogen or Ci-6 alkyl; each Reis independently Rhor Rd; each m is independently an integer from 0 to 2; and each n is independently an integer from 0 to 2; and a phytologically acceptable carrier.

48. The pesticidal composition of claim 47, wherein the pesticide comprises an acaricide, fungicide, herbicide, insecticide, molluscicide, nematocide, or a combination thereof.

49. A fungicidal composition, comprising a fungicide; a compound of the formulaor an agriculturally acceptable salt, solvate and / or N-oxide thereof, whereinZ1and Z2are each independently selected from a group consisting of hydrogen, Ci-6 alkyl; or Z1together with Z2and the atoms to which Z1and Z2are attached, forms a 5- or 6- membered ring optionally substituted with one or more of Ra;146wherein the 5- or 6-membered ring is optionally a heterocyclyl ring with one or more heteroatom groups selected from O, N, -N(Re)-, S, -S(0)-, -SO2-;R1is independently selected from a group consisting of hydrogen, C1-6 alkyl, optionally substituted with one or more Ra;R2is selected from hydrogen and C1-6 alkyl;X is -(CRaRb)n-Y;Y is selected from the group consisting of Ra, Rb, Rasubstituted with one or more of the same or different R8, Raor Rb, -0Rasubstituted with one or more of the same or different Raor Rb; -S(O)R8, -S(O)2R8, -N(Rd)S(O)2R8, -S(O)NRCRC, -S(O)2-NRCRC, -OS(O)Rd, -OS(O)2Rd, -OS(O)2ORd, -C(O)OR8, -C(O)R8, -OC(O)R8, -C(O)NRCRC, -NRCRC, -N(Rd)-C(O)R8, -N(Rd)-C(O)OR8, N(Rd)-C(O)NRcRc, -SR8. -(CH2)mR8, -OC(O)-(CH2)m-C(O)R8, -CHRCRC;R8is selected from the group consisting of Ra, Rb, Rasubstituted with one or more of the same or different Raor Rb, -CH2Rasubstituted with one or more of the same or different Raor Rb, -0Rasubstituted with one or more of the same or different Raor Rb; each Rais independently selected from hydrogen, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 haloalkyl, C3-8 cycloalkyl, Ce-io aryl, C5-10 heteroaryl, Ce-16 arylalkyl, 2-6 membered heteroalkyl and 3-8 membered heterocyclylalkyl;Rbis independently selected from the group consisting of =0, -0Ra, halogen, C1-3 haloalkyloxy, -OCF3, =S, -SRd, =NRd, =N0Rd, -NRCRC, -SF5, halogen, -CF3, -CN, -N02, -S(O)Rd, -S(O)2Rd, -S(O)2ORd, -N(H)S(O)2Rd, -S(O)NRCRC, -S(O)2NRCRC, -OS(O)Rd, -OS(O)2Rd. -OS(O)2ORd, -OS(O)2NRCRC, -C(O)Rd, -C(O)ORd, -C(0)NReRc, -C(NH)NRCRC, -C(NRa)NRcRc, -C(N0H)Ra, -C(NOH)NRCRC, -OC(O)Rd, -OC(O)ORd, -0C(0)NRcRc, -OC(NH)NRCRC, -0C(NRa)NRcRc, -[NHC(O)]„Rd, -[NRaC(0)]„Rd, -[NHC(O)]„ORd, -[NRaC(O)]„ORd. -[NHC(O)]„NRCRC. -[NRaC(O)]„NRcRc, -[NHC(NH)]„NRCRCand -[NRaC(NRa)]„NRcRc; each Rcis hydrogen, R8, or, alternatively, two Rcare taken together with the atom to which they are bonded to form a 5 to 10-membered cycloalkyl or heterocyclylalkyl which may optionally be substituted with one or more of the same or different Regroups;147each Rdis independently hydrogen or Ci-6 alkyl; each Reis independently Rhor Rd; each m is independently an integer from 0 to 2; and each n is independently an integer from 0 to 2; and a phytologically acceptable carrier.

50. The composition of claim 49, wherein the fungicide is selected from the group consisting of benzimidazoles, dicarboximides, phenylpyrroles, anilinopyrimidines, hydroxy anilides, carboxamides, phenyl amides, phosphonates, cinnamic acids, oxysterol binding protein inhibitors, triazole carboxamides, cymoxanil, carbamates, benzamides, demethylation inhibiting piperazines, demethylation inhibiting pyrimidines, demethylation inhibiting azoles, including imidazoles and triazoles, cyproconazole, difenoconazole, fenbuconazole, flutriafol, mefentrifluconazole, metconazole, ipconazole, prothioconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole. morpholines, cyflufenamid, metrafenone. pyriofenone, strobilurins, copper ammonium complex, copper hydroxide, copper oxide, copper oxychloride, copper sulfate, sulfur, lime sulfur, ethylenebisdithiocarbamates, aromatic hydrocarbons, phthalimides, guanidines, polyoxins, fluazinam, thiazolidines and combinations thereof.148

Images